﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2011v1.2">
  <ReturnHeader binaryAttachmentCount="0">
    <Timestamp>2012-08-20T13:19:51-05:00</Timestamp>
    <TaxPeriodEndDate>2011-12-31</TaxPeriodEndDate>
    <PreparerFirm>
      <EIN>521855942</EIN>
      <PreparerFirmBusinessName>
        <BusinessNameLine1>TATE AND TRYON</BusinessNameLine1>
      </PreparerFirmBusinessName>
      <PreparerFirmUSAddress>
        <AddressLine1>2021 L STREET NW SUITE 400</AddressLine1>
        <City>WASHINGTON</City>
        <State>DC</State>
        <ZIPCode>20036</ZIPCode>
      </PreparerFirmUSAddress>
    </PreparerFirm>
    <ReturnType>990</ReturnType>
    <TaxPeriodBeginDate>2011-01-01</TaxPeriodBeginDate>
    <Filer>
      <EIN>311667995</EIN>
      <Name>
        <BusinessNameLine1>CONQUER CANCER FOUNDATION OF THE</BusinessNameLine1>
        <BusinessNameLine2>AMERICAN SOCIETY OF CLINICAL ONCOLOGY</BusinessNameLine2>
      </Name>
      <NameControl>CONQ</NameControl>
      <Phone>5714831700</Phone>
      <USAddress>
        <AddressLine1>2318 MILL ROAD 800</AddressLine1>
        <City>ALEXANDRIA</City>
        <State>VA</State>
        <ZIPCode>22314</ZIPCode>
      </USAddress>
    </Filer>
    <Officer>
      <Name>PAUL AINES</Name>
      <Title>CFO</Title>
      <Phone>5714831300</Phone>
      <DateSigned>2012-08-20</DateSigned>
      <AuthorizeThirdParty>1</AuthorizeThirdParty>
    </Officer>
    <Preparer>
      <Name>DEBORAH G KOSNETT</Name>
      <PTIN>P00290720</PTIN>
      <Phone>2022932200</Phone>
    </Preparer>
    <TaxYear>2011</TaxYear>
    <BuildTS>2016-02-24 21:20:13Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCount="10">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001">
      <NameOfPrincipalOfficerPerson>ALLEN LICHTER MD</NameOfPrincipalOfficerPerson>
      <AddressPrincipalOfficerUS>
        <AddressLine1>2318 MILL ROAD 800</AddressLine1>
        <City>ALEXANDRIA</City>
        <State>VA</State>
        <ZIPCode>22314</ZIPCode>
      </AddressPrincipalOfficerUS>
      <GrossReceipts>38187636</GrossReceipts>
      <GroupReturnForAffiliates>0</GroupReturnForAffiliates>
      <Organization501c3>X</Organization501c3>
      <WebSite>WWW.CONQUERCANCERFOUNDATION.ORG</WebSite>
      <TypeOfOrganizationCorporation>X</TypeOfOrganizationCorporation>
      <YearFormation>1999</YearFormation>
      <StateLegalDomicile>VA</StateLegalDomicile>
      <ActivityOrMissionDescription>CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (CCF) IS THE PHILANTHROPIC ARM OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, INC. (ASCO). CCF'S FUNDING OF BREAKTHROUGH RESEARCH, PATIENT INFORMATION, PROFESSIONAL EDUCATION, AND QUALITY IMPROVEMENT PROGRAMS IN CANCER CARE GIVES PATIENTS AND CAREGIVERS POWERFUL RESOURCES TO ADDRESS THE DISEASE. THROUGH THESE EFFORTS, CCF IMPROVES THE LIVES OF THOSE IMPACTED BY CANCER.</ActivityOrMissionDescription>
      <NbrVotingMembersGoverningBody>12</NbrVotingMembersGoverningBody>
      <NbrIndependentVotingMembers>11</NbrIndependentVotingMembers>
      <TotalNbrEmployees>0</TotalNbrEmployees>
      <TotalNbrVolunteers>116</TotalNbrVolunteers>
      <TotalGrossUBI>0</TotalGrossUBI>
      <NetUnrelatedBusinessTxblIncome>0</NetUnrelatedBusinessTxblIncome>
      <ContributionsGrantsPriorYear>24400007</ContributionsGrantsPriorYear>
      <ContributionsGrantsCurrentYear>23070515</ContributionsGrantsCurrentYear>
      <ProgramServiceRevenuePriorYear>0</ProgramServiceRevenuePriorYear>
      <ProgramServiceRevenueCY>0</ProgramServiceRevenueCY>
      <InvestmentIncomePriorYear>265673</InvestmentIncomePriorYear>
      <InvestmentIncomeCurrentYear>902480</InvestmentIncomeCurrentYear>
      <OtherRevenuePriorYear>0</OtherRevenuePriorYear>
      <OtherRevenueCurrentYear>0</OtherRevenueCurrentYear>
      <TotalRevenuePriorYear>24665680</TotalRevenuePriorYear>
      <TotalRevenueCurrentYear>23972995</TotalRevenueCurrentYear>
      <GrantsAndSimilarAmntsPriorYear>20649143</GrantsAndSimilarAmntsPriorYear>
      <GrantsAndSimilarAmntsCY>16237145</GrantsAndSimilarAmntsCY>
      <BenefitsPaidToMembersPriorYear>0</BenefitsPaidToMembersPriorYear>
      <BenefitsPaidToMembersCY>0</BenefitsPaidToMembersCY>
      <SalariesEtcPriorYear>0</SalariesEtcPriorYear>
      <SalariesEtcCurrentYear>0</SalariesEtcCurrentYear>
      <TotalProfFundrsngExpPriorYear>199150</TotalProfFundrsngExpPriorYear>
      <TotalProfFundrsngExpCY>534850</TotalProfFundrsngExpCY>
      <TotalFundrsngExpCurrentYear>2059964</TotalFundrsngExpCurrentYear>
      <OtherExpensePriorYear>3843443</OtherExpensePriorYear>
      <OtherExpensesCurrentYear>3999492</OtherExpensesCurrentYear>
      <TotalExpensesPriorYear>24691736</TotalExpensesPriorYear>
      <TotalExpensesCurrentYear>20771487</TotalExpensesCurrentYear>
      <RevenuesLessExpensesPriorYear>-26056</RevenuesLessExpensesPriorYear>
      <RevenuesLessExpensesCY>3201508</RevenuesLessExpensesCY>
      <TotalAssetsBOY>36185072</TotalAssetsBOY>
      <TotalAssetsEOY>36980488</TotalAssetsEOY>
      <TotalLiabilitiesBOY>9750810</TotalLiabilitiesBOY>
      <TotalLiabilitiesEOY>8631006</TotalLiabilitiesEOY>
      <NetAssetsOrFundBalancesBOY>26434262</NetAssetsOrFundBalancesBOY>
      <NetAssetsOrFundBalancesEOY>28349482</NetAssetsOrFundBalancesEOY>
      <InfoInScheduleOPartIII>X</InfoInScheduleOPartIII>
      <MissionDescription>THE MISSION STATEMENT FOR CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (CCF) IS: CONQUERING CANCER WORLDWIDE BY FUNDING BREAKTHROUGH RESEARCH AND SHARING CUTTING-EDGE KNOWLEDGE. CCF'S VISION IS A WORLD FREE FROM THE FEAR OF CANCER.</MissionDescription>
      <SignificantNewProgramServices>0</SignificantNewProgramServices>
      <SignificantChange>0</SignificantChange>
      <Expense>8446472</Expense>
      <Grants>7961750</Grants>
      <Description>PROFESSIONAL EDUCATION - THE FIELD OF ONCOLOGY IS A DYNAMIC ARENA WHERE DEVELOPMENTS AND DISCOVERIES OCCUR NEARLY EVERY DAY. STAYING ABREAST OF THESE DEVELOPMENTS IS CRITICAL IN ALLOWING CANCER PHYSICIANS AND OTHER HEALTHCARE PROFESSIONALS TO PROVIDE EACH PERSON WITH CANCER THE BEST TREATMENT OPTIONS AVAILABLE. THROUGH ITS SUPPORT OF THE EDUCATIONAL AND SCIENTIFIC PROGRAMS OF ITS NON-PROFIT, CHARITABLE, RELATED ORGANIZATION, THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, THE FOUNDATION PROVIDES EDUCATIONAL AND SCIENTIFIC OPPORTUNITIES FOR ONCOLOGISTS AND OTHER HEALTHCARE PROFESSIONALS FROM AROUND THE GLOBE. TO ENSURE THAT THE HIGHEST-QUALITY CANCER EDUCATION CONTINUES TO BE AVAILABLE TO DOCTORS IN AN INDEPENDENT AND UNBIASED FORUM, FUNDS FROM CCF ARE USED TO SUPPORT ASCO'S COMPREHENSIVE SCIENTIFIC AND EDUCATIONAL PROGRAMS THAT PROVIDE THE LATEST DATA TO CANCER DOCTORS AND OTHER HEALTHCARE PROFESSIONALS WORLDWIDE THROUGH BOTH LIVE MEETINGS AND PRINT AND ELECTRONIC EDUCATION OFFERINGS. HIGHLIGHTS OF THE PROFESSIONAL EDUCATIONAL AND SCIENTIFIC MEETINGS SUPPORTED BY CCF AND PRESENTED TO THE PUBLIC IN 2011 INCLUDE: * THE 2011 ANNUAL MEETING FEATURED NEARLY 250 EDUCATIONAL AND SCIENTIFIC SESSIONS. OVER 4,000 ABSTRACTS WERE PRESENTED OR PUBLISHED. OVER 1,000 PRESENTATIONS WERE CAPTURED IN AUDIO AND VIDEO TO BE MADE AVAILABLE ELECTRONICALLY. THE ASCO ANNUAL MEETING IS THE WORLD'S PREMIER SCIENTIFIC AND EDUCATIONAL EVENT IN THE ONCOLOGY COMMUNITY. IT IS STRUCTURED AS A SERIES OF EDUCATIONAL AND SCIENTIFIC SESSIONS IN DISEASE-SPECIFIC OR ONCOLOGY-RELATED TOPICS. * GI SYMPOSIUM - THE ANNUAL GASTROINTESTINAL CANCERS SYMPOSIUM IS THE PREMIERE MULTIDISCIPLINARY GI CANCER SCIENTIFIC AND EDUCATIONAL MEETING OFFERING THE MOST UP-TO-DATE STRATEGIES IN PREVENTION, SCREENING, AND TREATMENT OF GASTROINTESTINAL CANCERS. THE SYMPOSIUM IS JOINTLY DEVELOPED BY THE AMERICAN GASTROENTEROLOGICAL ASSOCIATION INSTITUTE, THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY, AND THE SOCIETY OF SURGICAL ONCOLOGY. * GU SYMPOSIUM - THE ANNUAL GENITOURINARY CANCERS SYMPOSIUM IS THE PREEMINENT GENITOURINARY CANCER SCIENTIFIC AND EDUCATIONAL MEETING PROVIDING THE LATEST STRATEGIES IN SCREENING, DIAGNOSIS, TREATMENT, MANAGEMENT AND CONTROVERSIES IN THE FIELD OF GENITOURINARY CANCERS. THE SYMPOSIUM IS JOINTLY DEVELOPED BY THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY, AND THE SOCIETY OF UROLOGIC ONCOLOGY. * BREAST CANCER SYMPOSIUM - THE ANNUAL BREAST CANCER SYMPOSIUM FEATURES PRESENTATIONS ON THE LATEST MULTIDISCIPLINARY RESEARCH FROM SELECTED, THEME-BASED TRANSLATIONAL AND CLINICAL ABSTRACTS, AS WELL AS RELATED EDUCATIONAL SESSIONS. THE SYMPOSIUM PROVIDES AN OPPORTUNITY FOR EDUCATION REGARDING THE MOST CUTTING-EDGE SCIENTIFIC RESEARCH IN BREAST CANCER TODAY. THE MEETING IS JOINTLY DEVELOPED BY THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, THE AMERICAN SOCIETY OF BREAST DISEASE, THE AMERICAN SOCIETY OF BREAST SURGEONS, THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY, THE NATIONAL CONSORTIUM OF BREAST CENTERS, INC., AND THE SOCIETY OF SURGICAL ONCOLOGY.* BEST OF ASCO HELD IN SEATTLE, WA AND MIAMI, FL - THE BEST OF ASCO MEETINGS ARE DESIGNED AS A WORKSHOP, FOCUSED ON THE PRESENTATION AND DISCUSSION OF 50 OF THE TOP ASCO ANNUAL MEETING ABSTRACTS. A PANEL OF ASCO EXPERTS SELECTS ABSTRACTS THAT HIGHLIGHT THE IMPORTANT SCIENTIFIC INFORMATION TO CREATE THE BEST OF ASCO MEETING PROGRAM. * ASCO/AACR METHODS WORKSHOP - THIS INTENSIVE ANNUAL WORKSHOP, IN COLLABORATION WITH THE AMERICAN ASSOCIATION OF CANCER RESEARCH, BRINGS TOGETHER CLINICAL FELLOWS AND JUNIOR FACULTY CLINICAL RESEARCHERS IN ALL ONCOLOGY SUBSPECIALTIES TO LEARN ABOUT THE ESSENTIALS OF EFFECTIVE CLINICAL TRIAL DESIGNS OF THERAPEUTIC INTERVENTIONS IN THE TREATMENT OF CANCER.HIGHLIGHTS OF PRINT AND ELECTRONIC PROFESSIONAL EDUCATION MATERIALS SUPPORTED BY CCF AND AVAILABLE TO THE PUBLIC IN 2011 INCLUDE: *PROCEEDINGS - THE PROCEEDINGS PUBLICATIONS FOR THE ASCO ANNUAL MEETING AND SELECT ASCO THEMATIC SYMPOSIA CONTAIN ALL THE ABSTRACTS SELECTED FOR PRESENTATION AT THE LIVE EDUCATIONAL MEETING AND ALLOWS THOSE NOT ABLE TO ATTEND ACCESS TO THE GROUND-BREAKING ABSTRACTS THAT WERE PRESENTED.*EDUCATIONAL BOOKS -THE ANNUAL MEETING EDUCATIONAL BOOK IS THE COMPREHENSIVE RESOURCE FOR EDUCATION SESSION MATERIALS, ALLOWING THE ENTIRE ONCOLOGY COMMUNITY TO BENEFIT FROM DISCUSSIONS OF CRITICAL RESEARCH UPDATES IN A POINT-OF-CARE CONTEXT. MANUSCRIPTS DISCUSS THE CURRENT STANDARDS OF CARE AND EXISTING TECHNOLOGIES BUT ALSO LOOK TOWARD THE FUTURE, DISCUSSING RESEARCH IMPROVEMENTS AND TRENDS AND TREATMENTS STILL ON THE HORIZON. *ABSTRACTS ON ASCO.ORG - ABSTRACTS ON ASCO.ORG PROVIDE THE RESULTS OF THE LATEST CLINICAL CANCER RESEARCH TO HEALTHCARE PROFESSIONALS INVOLVED IN MULTIDISCIPLINARY CLINICAL CANCER CARE. THE ABSTRACTS ON ASCO.ORG COMPRISE ASCO'S COMPREHENSIVE ONLINE DATABASE OF ONCOLOGY-RELATED RESEARCH ABSTRACTS FROM ASCO SCIENTIFIC AND EDUCATIONAL MEETINGS DATING BACK TO 1995.*VIRTUAL MEETINGS ON ASCO.ORG - THE VIRTUAL MEETINGS WEBSITE PROVIDES THE RESULTS OF THE LATEST CLINICAL CANCER RESEARCH TO HEALTHCARE PROFESSIONALS INVOLVED IN MULTIDISCIPLINARY CLINICAL CANCER CARE. EACH SESSION INCLUDED ON THE VIRTUAL MEETINGS HAS ITS OWN OBJECTIVES. THE VIRTUAL MEETINGS ON ASCO.ORG USE THE LATEST TECHNOLOGY TO DELIVER OVER 25,000 ORAL PRESENTATIONS, ABSTRACTS, AND POSTERS FROM ASCO SCIENTIFIC AND EDUCATIONAL MEETINGS DATING BACK TO 1999 - THE MOST COMPREHENSIVE COLLECTION OF ONCOLOGY-RELATED MULTIMEDIA LECTURES AVAILABLE ON THE WEB.*ONLINE PORTALS - ASCO WEBSITES PROVIDE FAST, EASY NAVIGATION AND ADVANCED SEARCH CAPABILITIES. THE ASCO ONLINE PLATFORM HOSTS DISEASE-SPECIFIC PORTAL SITES. THESE "CANCER PORTALS" ARE ORGANIZED THEMATICALLY TO ALLOW SITE USERS TO EASILY ACCESS THE WEALTH OF DISEASE-SPECIFIC INFORMATION AVAILABLE. *ASCO UNIVERSITY - ASCO UNIVERSITY IS AN ONLINE EDUCATIONAL PLATFORM THAT IS A RESOURCE FOR EDUCATION AND INFORMATION FOR ONCOLOGISTS. ASCO UNIVERSITY SERVES AS THE EDUCATIONAL HOME AND SOURCE FOR LIFE-LONG LEARNING ACTIVITIES FOR PRACTICING ONCOLOGISTS AND THE NEXT GENERATION OF FELLOWS AND RESIDENTS. THE ACTIVITIES ON ASCO UNIVERSITY INCORPORATE FLEXIBLE, ROBUST CURRICULA WITH COLLATERAL PRODUCTS THAT TRANSLATE KEY ADULT LEARNING PRINCIPLES INTO INTERACTIVE EDUCATIONAL EXPERIENCES.</Description>
      <Activity2>
        <Expense>8340286</Expense>
        <Grants>7098612</Grants>
        <Description>RESEARCH - IN THIS AGE OF SCIENTIFIC PROMISE, FEDERAL FUNDS FOR CANCER RESEARCH ARE DECLINING. FULFILLING THE PROMISE OF TODAY'S ADVANCES RELIES ON FUNDING FOR RESEARCH PROJECTS AND SUPPORT FOR INVESTIGATORS WHO WISH TO PURSUE A CAREER IN CLINICAL AND TRANSLATIONAL CANCER RESEARCH. WITHOUT CONTINUED, WELL-TARGETED RESEARCH, THERE WOULD BE NO MEANINGFUL PROGRESS. AS A CHARITABLE ORGANIZATION, THE FOUNDATION SUPPORTS PROGRESS BY FUNDING CANCER RESEARCHERS AT ALL STAGES OF THEIR CAREERS, ENABLING ONCOLOGY'S BEST AND BRIGHTEST TO PURSUE PROMISING RESEARCH. EACH YEAR, CCF FUNDS AND AWARDS MULTIPLE RESEARCH GRANTS DESIGNED TO HELP ATTRACT AND RETAIN THE BEST SCIENTIFIC MINDS IN CANCER RESEARCH AND TO SUPPORT THEIR EFFORTS. HIGHLIGHTS OF 2011 RESEARCH ACTIVITIES AND ACCOMPLISHMENTS INCLUDE:IMPROVING CANCER CARE GRANT FUNDED BY SUSAN G. KOMEN FOR THE CURE(R) (ICCG) - $1.35 MILLION PROVIDED A GRANT TO ADDRESS IMPORTANT ISSUES REGARDING ACCESS TO HEALTHCARE, QUALITY OF CARE, AND DELIVERY OF CARE, WITH GENERAL APPLICABILITY TO BREAST CANCER. THE GOAL OF THIS PROGRAM WAS TO ENCOURAGE MULTI-DISCIPLINARY RESEARCH THAT WILL HAVE A MAJOR IMPACT ON CANCER CARE, WITH GENERAL APPLICABILITY IN THE BREAST CANCER ARENA.ADVANCED CLINICAL RESEARCH AWARD (ACRA)-$450,000 IN FUNDING PROVIDED ONE (1) THREE-YEAR AWARD INTENDED TO FUND INVESTIGATORS WHO ARE COMMITTED TO A CLINICAL CANCER STUDY AND WHO WISH TO CONDUCT ORIGINAL RESEARCH CURRENTLY NOT FUNDED. TRANSLATIONAL RESEARCH PROFESSORSHIP AWARD (TRP)-$300,000 IN FUNDING PROVIDED A THREE-YEAR AWARD DESIGNED TO PROVIDE FLEXIBLE FUNDING TO AN OUTSTANDING RESEARCHER WHO HAS MADE, AND IS CONTINUING TO MAKE, SIGNIFICANT CONTRIBUTIONS THAT HAVE CHANGED THE DIRECTION OF CANCER RESEARCH, AND WHO PROVIDES MENTORSHIP TO FUTURE TRANSLATIONAL RESEARCHERS. CAREER DEVELOPMENT AWARD (CDA)- $2,000,000 IN FUNDING PROVIDED TEN (10)THREE-YEAR AWARDS INTENDED TO SUPPORT CLINICAL RESEARCH OF CLINICAL INVESTIGATORS WHO HAVE RECEIVED THEIR INITIAL FACULTY APPOINTMENT AND ARE ESTABLISHING AN INDEPENDENT CLINICAL CANCER RESEARCH PROGRAM. YOUNG INVESTIGATOR AWARD (YIA)-$2,700,000 IN FUNDING PROVIDED FIFTY-FOUR (54)ONE-YEAR AWARDS DESIGNED TO ENCOURAGE AND PROMOTE HIGH-QUALITY RESEARCH IN CLINICAL ONCOLOGY BY PROVIDING FUNDS TO PROMISING INVESTIGATORS DURING THE TRANSITION FROM A FELLOWSHIP PROGRAM TO A FACULTY APPOINTMENT. LONG-TERM INTERNATIONAL FELLOWSHIP (LIFE) - $230,000 IN FUNDING PROVIDED TWO (2) ONE-YEAR FELLOWSHIPS TO AN EARLY-CAREER ONCOLOGIST IN A DEVELOPING COUNTRY THE SUPPORT AND RESOURCES NEEDED TO ADVANCE THEIR TRAINING BY DEEPENING THEIR RELATIONSHIP WITH A UNITED STATES OR CANADIAN COLLEAGUE AND HIS OR HER INSTITUTION.GIANNI BONADONNA BREAST CANCER RESEARCH FELLOWSHIP -$50,000 IN FUNDING PROVIDED A ONE-YEAR FELLOWSHIP THAT ENABLES AN EARLY-CAREER INVESTIGATOR TO UNDERTAKE A BREAST CANCER PROJECT UNDER THE MENTORSHIP OF THE GIANNI BONADONNA BREAST AWARD RECIPIENTCLINICAL TRIALS PARTICIPATION AWARD (CTPA)-$12,000 IN FUNDING PROVIDED A PROGRAM THAT PUBLICLY HONORS HIGH-QUALITY, COMMUNITY-BASED ONCOLOGY PRACTICES AND INSTITUTIONS THAT ACTIVELY PARTICIPATE IN CLINICAL TRIALS RESEARCH. THIS PROGRAM IS DESIGNED TO ENCOURAGE ONCOLOGY PRACTICES THAT CURRENTLY PARTICIPATE IN CLINICAL TRIALS TO INCREASE THEIR ACCRUAL RATES IN ORDER TO SUPPORT CANCER RESEARCH AND ADVANCES. COMMUNITY ONCOLOGY RESEARCH GRANTS (CORG) - $90,000 IN FUNDING PROVIDED THREE ONE-YEAR GRANTS TO COMMUNITY-BASED PRACTICES TO SUPPORT THEIR EFFORTS TO ENHANCE THEIR CLINICAL TRIALS PROGRAM. MERIT AWARDS- $223,000 PROVIDED FUNDING FOR THE BRADLEY STUART BELLER MERIT AWARD ALONG WITH 172 MERIT AWARDS WHICH RECOGNIZE CLINICAL RESEARCH CONDUCTED BY YOUNG SCIENTISTS AND PROVIDE FELLOWS WITH AN OPPORTUNITY TO PRESENT THEIR RESEARCH AND INTERACT WITH OTHER CLINICAL CANCER INVESTIGATORS AT ASCO SCIENTIFIC MEETINGS AND DISEASE-SPECIFIC SYMPOSIA. A SELECT NUMBER OF MERIT AWARDS WERE GIVEN OUT TO RECOGNIZE OUTSTANDING RESEARCH REFLECTED IN ABSTRACTS SUBMITTED FOR PRESENTATION AT DIFFERENT ASCO SCIENTIFIC MEETINGS.ONCOLOGY TRAINEE TRAVEL AWARDS- $244,000 IN FUNDING PROVIDED FOR 103 AWARDS TO SUPPORT CONTINUING EDUCATION AND PROFESSIONAL DEVELOPMENT OF TRAINEE ONCOLOGISTS AND ENCOURAGE A FOCUS ON CLINICAL ONCOLOGY.STATE AFFILIATE GRANT PROGRAM- ASCO CREATED THE STATE AFFILIATE GRANT PROGRAM TO SUPPORT ACTIVITIES AND PROGRAMS OF ITS SEPARATELY INCORPORATED STATE/REGIONAL AFFILIATES. IN 2011, $50,000 IN FUNDING PROVIDED FIVE AFFILIATES GRANTS TO ENGAGE IN PROJECTS.CCF ALSO RAISED FUNDS FOR A NUMBER OF AWARDS PROVIDED BY ASCO IN ORDER TO RECOGNIZE AND ENCOURAGE INDIVIDUALS OR ORGANIZATIONS THAT HAVE MADE SIGNIFICANT CONTRIBUTIONS TO ASCO, THE PRACTICE OF CLINICAL ONCOLOGY, AND CANCER PATIENTS. HIGHLIGHTS OF AWARDS SUPPORTED BY THE FOUNDATION IN 2011 INCLUDED:GIANNI BONADONNA BREAST CANCER AWARD AND LECTURE- THIS AWARD RECOGNIZED AN ACTIVE CLINICAL OR TRANSLATIONAL RESEARCHER WITH A DISTINGUISHED RECORD OF ACCOMPLISHMENTS IN ADVANCING THE FIELD OF BREAST CANCER AS WELL AS EXCEPTIONAL MENTORING ABILITIES. THE AWARD WINNER GAVE A LECTURE DURING THE BREAST CANCER SYMPOSIUM.BJ KENNEDY AWARD AND LECTURE- THIS AWARD RECOGNIZED A GERIATRIC ONCOLOGIST WHO HAS DEMONSTRATED OUTSTANDING LEADERSHIP AND ACHIEVEMENT IN THE FIELD OF GERIATRIC ONCOLOGY. THE AWARD WINNER GAVE A LECTURE DURING THE ASCO ANNUAL MEETING.AMERICAN CANCER SOCIETY AWARD AND LECTURE - THIS AWARD RECOGNIZED AN ONCOLOGIST THAT HAS MADE A SIGNIFICANT CONTRIBUTION TO CANCER PREVENTION AND CONTROL RESEARCH OR PRACTICE. THE AWARD IS JOINTLY SUPPORTED BY THE AMERICAN CANCER SOCIETY. THE AWARD WINNER GAVE A LECTURE DURING THE ASCO ANNUAL MEETING.INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD (IDEA)-THIS AWARD PROVIDES SUPPORT FOR ONCOLOGISTS IN DEVELOPING COUNTRIES TO PARTICIPATE IN THE ASCO ANNUAL MEETING AND VISIT A CANCER CENTER IN THE UNITED STATES OR CANADA. THIS AWARD WAS DESIGNED TO PROVIDE CONTINUING MEDICAL EDUCATION, AND ASSIST IN CAREER DEVELOPMENT TO ENHANCE THE QUALITY OF CANCER CARE WORLDWIDE.</Description>
      </Activity2>
      <Activity3>
        <Expense>607431</Expense>
        <Grants>606331</Grants>
        <Description>QUALITY AND ACCESS TO CARE-ADVANCES IN CANCER CARE ARE OCCURRING MORE AND MORE FREQUENTLY. YET, THE FULL PROMISE OF SUCH PROGRESS CANNOT BE REALIZED UNTIL HIGH-QUALITY CANCER CARE IS AVAILABLE TO EVERYONE. CONQUER CANCER FOUNDATION IS AWARE OF THE DIVIDE BETWEEN THOSE WITH ACCESS TO THE FRUITS OF RESEARCH AND TIMELY CARE, AND THOSE WITHOUT. STATE/REGIONAL AFFILIATE PROGRAM-THE ASCO STATE/REGIONAL AFFILIATE PROGRAM IS DESIGNED TO ADDRESS THE CHALLENGES IN THE PRACTICE OF ONCOLOGISTS ON THE LOCAL LEVEL IN THE EVER-CHANGING HEALTHCARE ENVIRONMENT. THE PROGRAM INCLUDES 48 STATE OR REGIONAL ONCOLOGY GROUPS RECEIVE EXPERTISE AND GUIDANCE ON WAYS TO STRENGTHEN THEIR ORGANIZATIONS, ENHANCE THEIR EDUCATIONAL ACTIVITIES, AND PROVIDE SUPPORT FOR THEIR MEMBERS TO IMPROVE THE QUALITY OF CANCER CARE. DIVERSITY IN ONCOLOGY INITIATIVE-THE CONQUER CANCER FOUNDATION GRANTS AND AWARDS PROGRAM OFFERS OR PROVIDES FUNDING FOR DIFFERENT TYPES OF AWARD OPPORTUNITIES FOR ONCOLOGY FELLOWS, CLINICAL PRACTICES, AND INTERNATIONAL RESEARCHERS. ONE OF THE PROGRAMS OFFERED THROUGH CCF IS THE ASCO DIVERSITY IN ONCOLOGY INITIATIVE, FUNDED BY SUSAN G. KOMEN FOR THE CURE(R). THE ASCO DIVERSITY IN ONCOLOGY INITIATIVE WAS STRUCTURED TO FACILITATE THE RECRUITMENT AND RETENTION OF INDIVIDUALS FROM POPULATIONS UNDERREPRESENTED IN MEDICINE TO CANCER CAREERS, WITH PARTICULAR ATTENTION TO THE DEVELOPMENT OF CLINICAL PRACTITIONERS AND INVESTIGATORS. IN 2011, $348,000 IN FUNDING PROVIDED TWO PROGRAMS FOR INDIVIDUALS INTERESTED OR CURRENTLY PRACTICING IN THE ONCOLOGY FIELD: LOAN REPAYMENT PROGRAM - THE ASCO LOAN REPAYMENT PROGRAM (LRP), FUNDED BY SUSAN G. KOMEN FOR THE CURE(R), PROVIDES REPAYMENT OF QUALIFYING EDUCATIONAL DEBT TO ONCOLOGISTS, OR TO ONCOLOGY FELLOWS UPON COMPLETION OF TRAINING, WHO COMMIT TO PRACTICING ONCOLOGY IN A MEDICALLY UNDERSERVED REGION OF THE UNITED STATES. IN 2011, $280,000 FUNDED FOUR (4) TWO-YEAR LOAN REPAYMENTS. MEDICAL STUDENT ROTATION - THE ASCO MEDICAL STUDENT ROTATION (MSR), FUNDED BY SUSAN G. KOMEN FOR THE CURE(R), PROVIDES 8- TO 10-WEEK CLINICAL OR CLINICAL RESEARCH ONCOLOGY ROTATIONS FOR U.S. MEDICAL STUDENTS FROM POPULATIONS UNDERREPRESENTED IN MEDICINE WHO ARE INTERESTED IN PURSUING ONCOLOGY AS A CAREER. IN 2011, $68,000 FUNDED EIGHT (8) MSRS. ALTHOUGH A NUMBER OF PROGRAMS EXIST TO RECRUIT INDIVIDUALS UNDERREPRESENTED IN MEDICINE, FEW OF THESE PROGRAMS FOCUS SPECIFICALLY ON RECRUITMENT TO CLINICAL ONCOLOGY. ULTIMATELY, IT IS HOPED THAT INCREASING DIVERSITY IN THE CLINICAL ONCOLOGY PROFESSION WILL LEAD TO INCREASED AND IMPROVED CANCER CARE FOR UNDERSERVED POPULATIONS AS WELL AS INCREASED RESEARCH ON HEALTH DISPARITIES. THE DIVERSITY IN ONCOLOGY INITIATIVE IS PART OF THE SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE, WHICH IS DESIGNED TO SUPPORT SPECIFIC PROJECTS ADDRESSING QUALITY CANCER CARE ISSUES, INCLUDING CANCER WORKFORCE, ACCESS TO CARE, DISPARITIES, CLINICAL TRIALS, AND SURVIVORSHIP, WITH GENERAL APPLICABILITY TO BREAST CANCER.</Description>
      </Activity3>
      <ActivityOther>
        <Expense>363264</Expense>
        <Grants>347044</Grants>
        <Description>PATIENT EDUCATION AND INFORMATION-WELL-INFORMED, EDUCATED PATIENTS ARE THEIR OWN BEST ADVOCATES, AS WELL AS INVALUABLE PARTNERS FOR DOCTORS. CCF SUPPORTS BOTH DOCTORS AND PATIENTS BY FUNDING ACCURATE, DOCTOR-APPROVED CANCER INFORMATION, WHICH IS AVAILABLE PUBLICLY BOTH IN PRINT AND ONLINE, TO PROVIDE TRUSTED, AUTHORITATIVE INFORMATION TO PEOPLE LIVING WITH CANCER AND THOSE WHO CARE FOR AND ABOUT THEM. FUNDING IN THIS AREA ALLOWS CCF TO CONTINUE AND EXPAND OUR WORK TO INFORM PATIENTS.HIGHLIGHTS OF PATIENT EDUCATION AND INFORMATION PROGRAMS AND ACTIVITIES SUPPORTED BY CCF IN 2011 INCLUDE:PATIENT ADVOCATE SCHOLARSHIP PROGRAM- THE PATIENT ADVOCATE SCHOLARSHIP PROGRAM PROVIDES TRAVEL GRANTS TO A SELECT NUMBER OF PATIENT ADVOCATES TO ATTEND THE ASCO ANNUAL MEETING AND ASCO DISEASE-SPECIFIC SYMPOSIA. IN 2011, CCF SUPPORTED THE ATTENDANCE OF PATIENT ADVOCATES AT THE 2011 ASCO ANNUAL MEETING AND ASCO DISEASE-SPECIFIC SYMPOSIA.ANSWERS TO CANCER PUBLIC FORUM- HELD DURING THE ASCO ANNUAL MEETING, THE PUBLIC FORUM IS AN IMPORTANT PROGRAM DESIGNED TO BRING PEOPLE AFFECTED BY CANCER TOGETHER TO LEARN FROM EACH OTHER, LEAN ON EACH OTHER, AND DISCUSS THE LATEST DISCOVERIES IN CANCER TREATMENT AND SURVIVORSHIP WITH THE WORLD'S TOP THOUGHT LEADERS IN CANCER CARE.CANCER.NET- CANCER.NET INCLUDES PEER-REVIEWED INFORMATION ON MORE THAN 124 TYPES OF CANCER AND SYNDROMES, INCLUDING RISK FACTORS, DIAGNOSIS, FINDING AN ONCOLOGIST , TREATMENT, MANAGING SIDE EFFECTS, CLINICAL TRIALS, AND AFTER TREATMENT, CAREGIVING, COPING STRATEGIES, AND SURVIVORSHIP. INFORMATION IS DELIVERED IN WRITTEN ARTICLES, VIDEOS, AND AUDIO PODCASTS. THIS INFORMATION IS MADE AVAILABLE FREE TO THE PUBLIC. IN 2011, THERE WERE MORE THAN 7,000,000 PAGE VIEWS OF CANCER.NET.CCF CONTINUES TO SUPPORT THE PRODUCTION OF ASCO'S PRINTED PATIENT INFORMATION MATERIALS, SUCH AS: ASCO ANSWERS FACT SHEETS- ASCO ANSWERS IS A SERIES OF FACT SHEETS THAT PROVIDE AN INTRODUCTION TO A SPECIFIC TYPE OF CANCER OR CANCER-RELATED TOPIC. EACH FACT SHEET INCLUDES AN OVERVIEW OF THE SUBJECT, TERMS TO KNOW, AND QUESTIONS TO ASK THE DOCTOR. PATIENT GUIDES- PATIENT GUIDES ARE PRINTED BOOKLETS CONTAINING COMPREHENSIVE CANCER INFORMATION; INCLUDING AN OVERVIEW OF SPECIFIC CANCER TYPES, SYMPTOMS, DIAGNOSIS, STAGING, TREATMENT, CLINICAL TRIALS, AND AFTER TREATMENT.INTERNATIONAL PROGRAMS-ASCO AND THE CONQUER CANCER FOUNDATION SHARE AN INTERNATIONAL MISSION TO ENGAGE THE PHYSICIAN AND HEALTHCARE PROFESSIONAL COMMUNITY ON A GLOBAL SCALE TO IMPROVE CARE TO CANCER PATIENTS AND ENHANCE THE EXCHANGE OF KNOWLEDGE TO FACILITATE ADVANCES IN THE CARE OF PEOPLE WITH CANCER EVERYWHERE. FOUNDATION FUNDS SUPPORT INTERNATIONAL PROGRAMS INCLUDING EDUCATION, FELLOWSHIP AND GRANT OPPORTUNITIES TO ENABLE ONCOLOGISTS FROM OPPOSITE ENDS OF THE WORLD TO SHARE IDEAS AND BUILD LASTING COLLABORATIONS THAT CAN ENHANCE PATIENT CARE LOCALLY AND GLOBALLY. CCF SUPPORTS THESE PROGRAMS THROUGH ITS INTERNATIONAL PROGRAM MISSION AS WELL AS THROUGH CCF'S OTHER MISSION AREAS (RESEARCH, PROFESSIONAL EDUCATION, PATIENT EDUCATION AND INFORMATION AND QUALITY AND ACCESS TO CARE).CCF FUNDS SPECIFICALLY SUPPORTING INTERNATIONAL ACTIVITIES INCLUDE: LONG-TERM INTERNATIONAL FELLOWSHIP (LIFE) PROVIDES EARLY-CAREER ONCOLOGISTS IN DEVELOPING NATIONS THE SUPPORT AND RESOURCES NEEDED TO ADVANCE THEIR TRAINING BY DEEPENING THEIR RELATIONSHIP WITH A UNITED STATES OR CANADIAN COLLEAGUE AND HIS OR HER INSTITUTION. THROUGH A ONE OR TWO YEAR FELLOWSHIP THE RECIPIENT WILL EARN VALUABLE TRAINING AND EXPERIENCE WITH WHICH THEY CAN AFFECT CHANGE IN CANCER CARE IN THEIR HOME COUNTRY. RECIPIENTS MUST RETURN TO THEIR HOME INSTITUTIONS AFTER COMPLETING THEIR FELLOWSHIP AND ARE EXPECTED TO DISSEMINATE THE KNOWLEDGE THEY HAVE GAINED.INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD (IDEA)-THE INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD PROVIDES SUPPORT FOR ONCOLOGISTS IN DEVELOPING COUNTRIES TO PARTICIPATE IN THE ASCO ANNUAL MEETING AND VISIT A CANCER CENTER IN THE UNITED STATES OR CANADA. THIS AWARD WAS DESIGNED TO PROVIDE CONTINUING MEDICAL EDUCATION, ASSIST IN CAREER DEVELOPMENT AND HELP TO ESTABLISH STRONG RELATIONSHIPS WITH LEADING ASCO MEMBERS WHO SERVE AS SCIENTIFIC MENTORS TO EACH RECIPIENT, TO ENHANCE THE QUALITY OF CANCER CARE WORLDWIDE. ADVANCED CANCER COURSES (ACC)-THE ADVANCED CANCER COURSES ARE CAREFULLY DESIGNED TO FILL THE NEED FOR ADVANCED LEARNING FOR INTERNATIONAL ONCOLOGISTS. THESE COURSES CAN BE CHOSEN FROM ASCO'S PORTFOLIO OF EDUCATIONAL PRODUCTS, OR DEVELOPED WITH THE COLLABORATION OF VOLUNTEER ONCOLOGISTS.</Description>
      </ActivityOther>
      <TotalOfOtherProgramServiceExp>363264</TotalOfOtherProgramServiceExp>
      <TotalOfOtherProgramServiceGrnt>347044</TotalOfOtherProgramServiceGrnt>
      <TotalProgramServiceExpense>17757453</TotalProgramServiceExpense>
      <DescribedIn501C3 referenceDocumentId="RetDoc1039100001">1</DescribedIn501C3>
      <ScheduleBRequired referenceDocumentId="RetDoc1234500001">1</ScheduleBRequired>
      <PoliticalActivities>0</PoliticalActivities>
      <LobbyingActivities>0</LobbyingActivities>
      <SubjectToProxyTax>0</SubjectToProxyTax>
      <DonorAdvisedFunds referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFunds>
      <ConservationEasements referenceDocumentId="RetDoc1040000001">0</ConservationEasements>
      <CollectionsOfArt referenceDocumentId="RetDoc1040000001">0</CollectionsOfArt>
      <CreditCounseling referenceDocumentId="RetDoc1040000001">0</CreditCounseling>
      <TermOrPermanentEndowments referenceDocumentId="RetDoc1040000001">1</TermOrPermanentEndowments>
      <ReportLandBldgEquip referenceDocumentId="RetDoc1040000001">0</ReportLandBldgEquip>
      <ReportInvestOthSecurities referenceDocumentId="RetDoc1040000001">0</ReportInvestOthSecurities>
      <ReportProgRelInvest referenceDocumentId="RetDoc1040000001">0</ReportProgRelInvest>
      <ReportOtherAssets referenceDocumentId="RetDoc1040000001">0</ReportOtherAssets>
      <ReportOtherLiabilities referenceDocumentId="RetDoc1040000001">1</ReportOtherLiabilities>
      <ReportFin48Footnote referenceDocumentId="RetDoc1040000001">1</ReportFin48Footnote>
      <IndependentAuditFinancialStmt referenceDocumentId="RetDoc1040000001">0</IndependentAuditFinancialStmt>
      <ConsolidatedAuditFinancialStmt referenceDocumentId="RetDoc1040000001">1</ConsolidatedAuditFinancialStmt>
      <School>0</School>
      <ForeignOffice>0</ForeignOffice>
      <ForeignActivities referenceDocumentId="RetDoc1040500001">1</ForeignActivities>
      <MoreThan5000KToOrganizations referenceDocumentId="RetDoc1040500001">1</MoreThan5000KToOrganizations>
      <MoreThan5000KToIndividuals referenceDocumentId="RetDoc1040500001">1</MoreThan5000KToIndividuals>
      <ProfessionalFundraising referenceDocumentId="RetDoc1041200001">1</ProfessionalFundraising>
      <FundraisingActivities referenceDocumentId="RetDoc1041200001">0</FundraisingActivities>
      <Gaming referenceDocumentId="RetDoc1041200001">0</Gaming>
      <Hospital>0</Hospital>
      <GrantsToOrganizations referenceDocumentId="RetDoc1041900001">1</GrantsToOrganizations>
      <GrantsToIndividuals referenceDocumentId="RetDoc1041900001">1</GrantsToIndividuals>
      <ScheduleJRequired referenceDocumentId="RetDoc1042400001">1</ScheduleJRequired>
      <TaxExemptBonds>0</TaxExemptBonds>
      <ExcessBenefitTransaction>0</ExcessBenefitTransaction>
      <PriorExcessBenefitTransaction>0</PriorExcessBenefitTransaction>
      <LoanToOfficerOrDQP>0</LoanToOfficerOrDQP>
      <GrantToRelatedPerson>0</GrantToRelatedPerson>
      <BsnssRltnshpWithOrganization>0</BsnssRltnshpWithOrganization>
      <BsnssRltnshpThruFamilyMember>0</BsnssRltnshpThruFamilyMember>
      <OfficerEntityWithBsnssRltnshp>0</OfficerEntityWithBsnssRltnshp>
      <DeductibleNonCashContributions>0</DeductibleNonCashContributions>
      <DeductibleContributionsOfArt>0</DeductibleContributionsOfArt>
      <Terminated>0</Terminated>
      <PartialLiquidation>0</PartialLiquidation>
      <DisregardedEntity referenceDocumentId="RetDoc1043400001">0</DisregardedEntity>
      <RelatedEntity referenceDocumentId="RetDoc1043400001">1</RelatedEntity>
      <RelatedOrgControlledEntity>0</RelatedOrgControlledEntity>
      <TransactionRelatedEntity referenceDocumentId="RetDoc1043400001">0</TransactionRelatedEntity>
      <TransfersToExemptNonChrtblOrg referenceDocumentId="RetDoc1043400001">0</TransfersToExemptNonChrtblOrg>
      <ActivitiesConductedPartnership referenceDocumentId="RetDoc1043400001">0</ActivitiesConductedPartnership>
      <ScheduleORequired>1</ScheduleORequired>
      <NumberFormsTransmittedWith1096>232</NumberFormsTransmittedWith1096>
      <NumberW2GIncluded>0</NumberW2GIncluded>
      <ComplianceWithBackupWitholding>1</ComplianceWithBackupWitholding>
      <NumberOfEmployees>0</NumberOfEmployees>
      <UnrelatedBusinessIncome>0</UnrelatedBusinessIncome>
      <ForeignFinancialAccount>0</ForeignFinancialAccount>
      <ProhibitedTaxShelterTrans>0</ProhibitedTaxShelterTrans>
      <TaxablePartyNotification>0</TaxablePartyNotification>
      <NonDeductibleContributions>0</NonDeductibleContributions>
      <QuidProQuoContributions>0</QuidProQuoContributions>
      <Form8282PropertyDisposedOf>0</Form8282PropertyDisposedOf>
      <FundsToPayPremiums>0</FundsToPayPremiums>
      <PremiumsPaid>0</PremiumsPaid>
      <IndoorTanningServices>0</IndoorTanningServices>
      <InfoInScheduleOPartVI>X</InfoInScheduleOPartVI>
      <NbrVotingGoverningBodyMembers>12</NbrVotingGoverningBodyMembers>
      <NumberIndependentVotingMembers>11</NumberIndependentVotingMembers>
      <FamilyOrBusinessRelationship>0</FamilyOrBusinessRelationship>
      <DelegationOfManagementDuties>0</DelegationOfManagementDuties>
      <ChangesToOrganizingDocs>1</ChangesToOrganizingDocs>
      <MaterialDiversionOrMisuse>0</MaterialDiversionOrMisuse>
      <MembersOrStockholders>0</MembersOrStockholders>
      <ElectionOfBoardMembers>1</ElectionOfBoardMembers>
      <DecisionsSubjectToApproval>1</DecisionsSubjectToApproval>
      <MinutesOfGoverningBody>1</MinutesOfGoverningBody>
      <MinutesOfCommittees>1</MinutesOfCommittees>
      <OfficerMailingAddress>0</OfficerMailingAddress>
      <LocalChapters>0</LocalChapters>
      <Form990ProvidedToGoverningBody>1</Form990ProvidedToGoverningBody>
      <ConflictOfInterestPolicy>1</ConflictOfInterestPolicy>
      <AnnualDisclosureCoveredPersons>1</AnnualDisclosureCoveredPersons>
      <RegularMonitoringEnforcement>1</RegularMonitoringEnforcement>
      <WhistleblowerPolicy>1</WhistleblowerPolicy>
      <DocumentRetentionPolicy>1</DocumentRetentionPolicy>
      <CompensationProcessCEO>1</CompensationProcessCEO>
      <CompensationProcessOther>1</CompensationProcessOther>
      <InvestmentInJointVenture>0</InvestmentInJointVenture>
      <StatesWhereCopyOfReturnIsFiled>AL</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>AK</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>AZ</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>AR</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>CA</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>CO</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>CT</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>ME</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>WA</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>FL</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>GA</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>HI</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>IL</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>KS</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>KY</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>MD</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>MA</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>MI</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>MN</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>MS</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>MO</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>NH</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>NJ</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>NM</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>NY</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>NC</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>ND</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>OH</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>OK</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>OR</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>PA</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>RI</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>SC</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>TN</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>UT</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>VA</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>WV</StatesWhereCopyOfReturnIsFiled>
      <StatesWhereCopyOfReturnIsFiled>WI</StatesWhereCopyOfReturnIsFiled>
      <OwnWebsite>X</OwnWebsite>
      <TheBooksAreInCareOf>
        <NamePerson>PAUL AINES CFO</NamePerson>
        <TelephoneNumber>5714831700</TelephoneNumber>
        <AddressUS>
          <AddressLine1>SAME AS C ABOVE</AddressLine1>
          <City>ALEXANDRIA</City>
          <State>VA</State>
          <ZIPCode>22314</ZIPCode>
        </AddressUS>
      </TheBooksAreInCareOf>
      <Form990PartVIISectionA>
        <NamePerson>MARTIN J MURPHY JR PHD DMEDSC</NamePerson>
        <Title>CHAIR</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>RICHARD L SCHILSKY MD</NamePerson>
        <Title>SECRETARY</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>ALLEN LICHTER MD</NamePerson>
        <Title>BOARD MEMBER; CEO</Title>
        <AverageHoursPerWeek>4.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>748894</ReportableCompFromRelatedOrgs>
        <OtherCompensation>20162</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>W CHARLES PENLEY MD</NamePerson>
        <Title>TREASURER</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>JOHN H GLICK MD</NamePerson>
        <Title>BOARD MEMBER</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>NORA ANITA JANJAN MD</NamePerson>
        <Title>BOARD MEMBER</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>750</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>ROBERT J MAYER MD</NamePerson>
        <Title>BOARD MEMBER</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>THOMAS A MARSLAND MD</NamePerson>
        <Title>BOARD MEMBER</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>SANDRA M SWAIN MD</NamePerson>
        <Title>BOARD MEMBER</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>IRA M ELEGANT ESQ</NamePerson>
        <Title>BOARD MEMBER</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>LAWRENCE H EINHORN MD</NamePerson>
        <Title>BOARD MEMBER</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>GABRIEL N HORTOBAGYI MD FACP</NamePerson>
        <Title>BOARD MEMBER</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>0</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>MICHAEL P LINK MD</NamePerson>
        <Title>BOARD MEMBER</Title>
        <AverageHoursPerWeek>1.00</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>10000</ReportableCompFromRelatedOrgs>
        <OtherCompensation>0</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>NANCY DALY MS MPH</NamePerson>
        <Title>BOARD MEMBER; CCF EXEC DIR</Title>
        <AverageHoursPerWeek>37.50</AverageHoursPerWeek>
        <IndividualTrusteeOrDirector>X</IndividualTrusteeOrDirector>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>210524</ReportableCompFromRelatedOrgs>
        <OtherCompensation>23931</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>DINA MICHELS ESQ</NamePerson>
        <Title>GENERAL COUNSEL</Title>
        <AverageHoursPerWeek>4.00</AverageHoursPerWeek>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>468167</ReportableCompFromRelatedOrgs>
        <OtherCompensation>34067</OtherCompensation>
      </Form990PartVIISectionA>
      <Form990PartVIISectionA>
        <NamePerson>PAUL AINES CPA</NamePerson>
        <Title>CFO</Title>
        <AverageHoursPerWeek>4.00</AverageHoursPerWeek>
        <Officer>X</Officer>
        <ReportableCompFromOrganization>0</ReportableCompFromOrganization>
        <ReportableCompFromRelatedOrgs>287362</ReportableCompFromRelatedOrgs>
        <OtherCompensation>32951</OtherCompensation>
      </Form990PartVIISectionA>
      <TotalReportableCompFromOrg>750</TotalReportableCompFromOrg>
      <TotalReportableCompFrmRltdOrgs>1724947</TotalReportableCompFrmRltdOrgs>
      <TotalOtherCompensation>111111</TotalOtherCompensation>
      <NumberIndividualsGT100K>0</NumberIndividualsGT100K>
      <FormersListed>0</FormersListed>
      <TotalCompGT150K>1</TotalCompGT150K>
      <CompensationFromOtherSources>0</CompensationFromOtherSources>
      <ContractorCompensation>
        <NameOfContractor>
          <NameBusiness>
            <BusinessNameLine1>GRAHAM PELTON</BusinessNameLine1>
          </NameBusiness>
        </NameOfContractor>
        <AddressOfContractor>
          <AddressUS>
            <AddressLine1>39 BEACHWOOD ROAD</AddressLine1>
            <City>SUMMIT</City>
            <State>NJ</State>
            <ZIPCode>07901</ZIPCode>
          </AddressUS>
        </AddressOfContractor>
        <DescriptionOfServices>FUNDRAISING CONSULTING</DescriptionOfServices>
        <Compensation>534850</Compensation>
      </ContractorCompensation>
      <ContractorCompensation>
        <NameOfContractor>
          <NameBusiness>
            <BusinessNameLine1>THE MERZ GROUP</BusinessNameLine1>
          </NameBusiness>
        </NameOfContractor>
        <AddressOfContractor>
          <AddressUS>
            <AddressLine1>1570 MCDANIEL DR</AddressLine1>
            <City>WEST CHESTER</City>
            <State>PA</State>
            <ZIPCode>19380</ZIPCode>
          </AddressUS>
        </AddressOfContractor>
        <DescriptionOfServices>BRAND CONSULTANT</DescriptionOfServices>
        <Compensation>168185</Compensation>
      </ContractorCompensation>
      <NumberOfContractorsGT100K>2</NumberOfContractorsGT100K>
      <FederatedCampaigns>11453</FederatedCampaigns>
      <RelatedOrganizations>2374454</RelatedOrganizations>
      <AllOtherContributions>20684608</AllOtherContributions>
      <NoncashContributions>5450</NoncashContributions>
      <TotalContributions>23070515</TotalContributions>
      <InvestmentIncome>
        <TotalRevenueColumn>731080</TotalRevenueColumn>
        <ExclusionAmount>731080</ExclusionAmount>
      </InvestmentIncome>
      <GrossAmountSalesAssets>
        <Securities>14386041</Securities>
      </GrossAmountSalesAssets>
      <LessCostOthBasisSalesExpenses>
        <Securities>14214641</Securities>
      </LessCostOthBasisSalesExpenses>
      <GainOrLoss>
        <Securities>171400</Securities>
      </GainOrLoss>
      <NetGainOrLossInvestments>
        <TotalRevenueColumn>171400</TotalRevenueColumn>
        <ExclusionAmount>171400</ExclusionAmount>
      </NetGainOrLossInvestments>
      <TotalRevenue>
        <TotalRevenueColumn>23972995</TotalRevenueColumn>
        <RelatedOrExemptFunctionIncome>0</RelatedOrExemptFunctionIncome>
        <UnrelatedBusinessRevenue>0</UnrelatedBusinessRevenue>
        <ExclusionAmount>902480</ExclusionAmount>
      </TotalRevenue>
      <GrantsToDomesticOrgs>
        <Total>15342976</Total>
        <ProgramServices>15342976</ProgramServices>
      </GrantsToDomesticOrgs>
      <GrantsToDomesticIndividuals>
        <Total>626669</Total>
        <ProgramServices>626669</ProgramServices>
      </GrantsToDomesticIndividuals>
      <ForeignGrants>
        <Total>267500</Total>
        <ProgramServices>267500</ProgramServices>
      </ForeignGrants>
      <FeesForServicesManagement>
        <Total>2551170</Total>
        <ProgramServices>1403144</ProgramServices>
        <ManagementAndGeneral>438801</ManagementAndGeneral>
        <Fundraising>709225</Fundraising>
      </FeesForServicesManagement>
      <FeesForServicesLegal>
        <Total>9812</Total>
        <ManagementAndGeneral>9812</ManagementAndGeneral>
      </FeesForServicesLegal>
      <FeesForServicesAccounting>
        <Total>5000</Total>
        <ManagementAndGeneral>5000</ManagementAndGeneral>
      </FeesForServicesAccounting>
      <FeesForServicesProfFundraising>
        <Total>534850</Total>
        <Fundraising>534850</Fundraising>
      </FeesForServicesProfFundraising>
      <FeesForServicesInvstMgmntFees>
        <Total>135273</Total>
        <ManagementAndGeneral>135273</ManagementAndGeneral>
      </FeesForServicesInvstMgmntFees>
      <FeesForServicesOther>
        <Total>37788</Total>
        <ManagementAndGeneral>37788</ManagementAndGeneral>
      </FeesForServicesOther>
      <Advertising>
        <Total>529786</Total>
        <Fundraising>529786</Fundraising>
      </Advertising>
      <OfficeExpenses>
        <Total>98556</Total>
        <ProgramServices>19426</ProgramServices>
        <ManagementAndGeneral>19999</ManagementAndGeneral>
        <Fundraising>59131</Fundraising>
      </OfficeExpenses>
      <InformationTechnology>
        <Total>24857</Total>
        <ManagementAndGeneral>24857</ManagementAndGeneral>
      </InformationTechnology>
      <Occupancy>
        <Total>231180</Total>
        <ProgramServices>64268</ProgramServices>
        <ManagementAndGeneral>39763</ManagementAndGeneral>
        <Fundraising>127149</Fundraising>
      </Occupancy>
      <Travel>
        <Total>180459</Total>
        <ProgramServices>14621</ProgramServices>
        <ManagementAndGeneral>113720</ManagementAndGeneral>
        <Fundraising>52118</Fundraising>
      </Travel>
      <ConferencesMeetings>
        <Total>34151</Total>
        <ManagementAndGeneral>34151</ManagementAndGeneral>
      </ConferencesMeetings>
      <OtherExpenses>
        <Description>DUES &amp; SUBSCRIPTIONS</Description>
        <Total>61419</Total>
        <ProgramServices>14745</ProgramServices>
        <ManagementAndGeneral>44414</ManagementAndGeneral>
        <Fundraising>2260</Fundraising>
      </OtherExpenses>
      <OtherExpenses>
        <Description>POSTAGE</Description>
        <Total>46943</Total>
        <ProgramServices>609</ProgramServices>
        <ManagementAndGeneral>889</ManagementAndGeneral>
        <Fundraising>45445</Fundraising>
      </OtherExpenses>
      <OtherExpenses>
        <Description>BANK &amp; CREDIT CARD FEES</Description>
        <Total>36413</Total>
        <ManagementAndGeneral>36413</ManagementAndGeneral>
      </OtherExpenses>
      <OtherExpenses>
        <Description>PRINTING &amp; DISTRIBUTION</Description>
        <Total>16685</Total>
        <ProgramServices>3495</ProgramServices>
        <ManagementAndGeneral>13190</ManagementAndGeneral>
      </OtherExpenses>
      <TotalFunctionalExpenses>
        <Total>20771487</Total>
        <ProgramServices>17757453</ProgramServices>
        <ManagementAndGeneral>954070</ManagementAndGeneral>
        <Fundraising>2059964</Fundraising>
      </TotalFunctionalExpenses>
      <CashNonInterestBearing>
        <BOY>-1446413</BOY>
        <EOY>4575939</EOY>
      </CashNonInterestBearing>
      <SavingsAndTempCashInvestments>
        <BOY>7295112</BOY>
        <EOY>668951</EOY>
      </SavingsAndTempCashInvestments>
      <PledgesAndGrantsReceivable>
        <BOY>6725883</BOY>
        <EOY>6883142</EOY>
      </PledgesAndGrantsReceivable>
      <AccountsReceivable>
        <BOY>1133</BOY>
      </AccountsReceivable>
      <PrepaidExpensesDeferredCharges>
        <BOY>30450</BOY>
        <EOY>81934</EOY>
      </PrepaidExpensesDeferredCharges>
      <InvestmentsPubTradedSecurities>
        <BOY>21727452</BOY>
        <EOY>24760586</EOY>
      </InvestmentsPubTradedSecurities>
      <InvestmentsOtherSecurities>
        <BOY>1454926</BOY>
        <EOY>9936</EOY>
      </InvestmentsOtherSecurities>
      <OtherAssetsTotal>
        <BOY>396529</BOY>
      </OtherAssetsTotal>
      <TotalAssets>
        <BOY>36185072</BOY>
        <EOY>36980488</EOY>
      </TotalAssets>
      <AccountsPayableAccruedExpenses>
        <BOY>7386469</BOY>
        <EOY>6381439</EOY>
      </AccountsPayableAccruedExpenses>
      <DeferredRevenue>
        <BOY>1306001</BOY>
        <EOY>1684113</EOY>
      </DeferredRevenue>
      <OtherLiabilities>
        <BOY>1058340</BOY>
        <EOY>565454</EOY>
      </OtherLiabilities>
      <TotalLiabilities>
        <BOY>9750810</BOY>
        <EOY>8631006</EOY>
      </TotalLiabilities>
      <FollowSFAS117>X</FollowSFAS117>
      <UnrestrictedNetAssets>
        <BOY>17511782</BOY>
        <EOY>18703836</EOY>
      </UnrestrictedNetAssets>
      <TemporarilyRestrictedNetAssets>
        <BOY>8840239</BOY>
        <EOY>9558405</EOY>
      </TemporarilyRestrictedNetAssets>
      <PermanentlyRestrictedNetAssets>
        <BOY>82241</BOY>
        <EOY>87241</EOY>
      </PermanentlyRestrictedNetAssets>
      <TotalNetAssetsFundBalances>
        <BOY>26434262</BOY>
        <EOY>28349482</EOY>
      </TotalNetAssetsFundBalances>
      <TotalLiabNetAssetsFundBalances>
        <BOY>36185072</BOY>
        <EOY>36980488</EOY>
      </TotalLiabNetAssetsFundBalances>
      <InfoInScheduleOPartXI>X</InfoInScheduleOPartXI>
      <ReconcilationRevenueExpenses>3201508</ReconcilationRevenueExpenses>
      <ReconcilationOtherChanges>-1286288</ReconcilationOtherChanges>
      <InfoInScheduleOPartXII>X</InfoInScheduleOPartXII>
      <MethodOfAccountingAccrual>X</MethodOfAccountingAccrual>
      <AccountantCompileOrReview>0</AccountantCompileOrReview>
      <FSAudited>1</FSAudited>
      <AuditCommittee>1</AuditCommittee>
      <FinancialStatementConsolidated>X</FinancialStatementConsolidated>
      <FederalGrantAuditRequired>0</FederalGrantAuditRequired>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <PubliclySupportedOrg170b1Avi>X</PubliclySupportedOrg170b1Avi>
      <GiftsGrantsContribReceived170>
        <CurrentTaxYearMinus4Years>5055674</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>32873924</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus2Years>24169849</CurrentTaxYearMinus2Years>
        <CurrentTaxYearMinus1Year>24400007</CurrentTaxYearMinus1Year>
        <CurrentTaxYear>23206830</CurrentTaxYear>
        <Total>109706284</Total>
      </GiftsGrantsContribReceived170>
      <Total170>
        <CurrentTaxYearMinus4Years>5055674</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>32873924</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus2Years>24169849</CurrentTaxYearMinus2Years>
        <CurrentTaxYearMinus1Year>24400007</CurrentTaxYearMinus1Year>
        <CurrentTaxYear>23206830</CurrentTaxYear>
        <Total>109706284</Total>
      </Total170>
      <AmountsSubstContributorsTotal>44405451</AmountsSubstContributorsTotal>
      <PublicSupportTotal170>65300833</PublicSupportTotal170>
      <GrossInvestmentIncome170>
        <CurrentTaxYearMinus4Years>238350</CurrentTaxYearMinus4Years>
        <CurrentTaxYearMinus3Years>481663</CurrentTaxYearMinus3Years>
        <CurrentTaxYearMinus2Years>195182</CurrentTaxYearMinus2Years>
        <CurrentTaxYearMinus1Year>136059</CurrentTaxYearMinus1Year>
        <CurrentTaxYear>595807</CurrentTaxYear>
        <Total>1647061</Total>
      </GrossInvestmentIncome170>
      <TotalSupport>111353345</TotalSupport>
      <PublicSupportPertcentage170>0.58640</PublicSupportPertcentage170>
      <PublicSupportPertcentPriorYear>0.54970</PublicSupportPertcentPriorYear>
      <ThirtyThreePercntTestsCY170>X</ThirtyThreePercntTestsCY170>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <ContributorInfo>
        <ContributorNumber>RESTRICTED</ContributorNumber>
        <ContributorNameBusiness>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorNameBusiness>
        <ContributorAddressUS>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorAddressUS>
        <AggregateContributions>RESTRICTED</AggregateContributions>
      </ContributorInfo>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <CurrentYear>
        <BeginningOfYearBalance>82241</BeginningOfYearBalance>
        <Contributions>5000</Contributions>
        <InvestmentEarningsOrLosses>-2594</InvestmentEarningsOrLosses>
        <GrantsOrScholarships>1948</GrantsOrScholarships>
        <EndOfYearBalance>82699</EndOfYearBalance>
      </CurrentYear>
      <CurrentYearMinus1Year>
        <BeginningOfYearBalance>116963</BeginningOfYearBalance>
        <Contributions>15930</Contributions>
        <InvestmentEarningsOrLosses>1348</InvestmentEarningsOrLosses>
        <GrantsOrScholarships>52000</GrantsOrScholarships>
        <EndOfYearBalance>82241</EndOfYearBalance>
      </CurrentYearMinus1Year>
      <CurrentYearMinus2Years>
        <BeginningOfYearBalance>103356</BeginningOfYearBalance>
        <Contributions>14492</Contributions>
        <InvestmentEarningsOrLosses>1115</InvestmentEarningsOrLosses>
        <GrantsOrScholarships>2000</GrantsOrScholarships>
        <EndOfYearBalance>116963</EndOfYearBalance>
      </CurrentYearMinus2Years>
      <CurrentYearMinus3Years>
        <BeginningOfYearBalance>154283</BeginningOfYearBalance>
        <InvestmentEarningsOrLosses>6573</InvestmentEarningsOrLosses>
        <GrantsOrScholarships>57500</GrantsOrScholarships>
        <EndOfYearBalance>103356</EndOfYearBalance>
      </CurrentYearMinus3Years>
      <BoardDesignatedEOYBalance>0.00000</BoardDesignatedEOYBalance>
      <PermanentEndowmentEOYBalance>1.00000</PermanentEndowmentEOYBalance>
      <TermEndowmentEOYBalance>0.00000</TermEndowmentEOYBalance>
      <EndowmentsHeldByUnrelatedOrgs>0</EndowmentsHeldByUnrelatedOrgs>
      <EndowmentsHeldByRelatedOrgs>0</EndowmentsHeldByRelatedOrgs>
      <TotalOfBookValueLandBuildings>0</TotalOfBookValueLandBuildings>
      <OtherLiabilities>
        <Description>DUE TO RELATED ORGANIZATION</Description>
        <Amount>565454</Amount>
      </OtherLiabilities>
      <TotalOfAmounts>565454</TotalOfAmounts>
      <TotalRevenue>23972995</TotalRevenue>
      <TotalExpenses>20771487</TotalExpenses>
      <ExcessOrDeficitForYear>3201508</ExcessOrDeficitForYear>
      <NetUnrealizedGLOnInvestments>-1286288</NetUnrealizedGLOnInvestments>
      <TotalAdjustments>-1286288</TotalAdjustments>
      <ExcessOrDeficitPerFS>1915220</ExcessOrDeficitPerFS>
      <TotRevenueEtcAuditedFinclStmt>22551434</TotRevenueEtcAuditedFinclStmt>
      <NetUnrealizedGainsInvestments>-1286288</NetUnrealizedGainsInvestments>
      <RevenueNotRptdF990>-1286288</RevenueNotRptdF990>
      <RevenueSubtotal>23837722</RevenueSubtotal>
      <InvestmentExpensesNotIncluded>135273</InvestmentExpensesNotIncluded>
      <RevenueNotRptdOnFinStmt>135273</RevenueNotRptdOnFinStmt>
      <TotalRevenuePerForm990>23972995</TotalRevenuePerForm990>
      <TotExpensesEtcAuditedFinclStmt>20636214</TotExpensesEtcAuditedFinclStmt>
      <ExpensesNotRptdF990>0</ExpensesNotRptdF990>
      <ExpensesSubtotal>20636214</ExpensesSubtotal>
      <InvestmentExpensesNotIncluded2>135273</InvestmentExpensesNotIncluded2>
      <ExpensesNotRptdOnFinStmt>135273</ExpensesNotRptdOnFinStmt>
      <TotalExpensesPerForm990>20771487</TotalExpensesPerForm990>
      <Form990ScheduleDPartXIV>
        <Identifier>DESCRIPTION OF INTENDED USE OF ENDOWMENT FUNDS:</Identifier>
        <ReturnReference>PART V, LINE 4:</ReturnReference>
        <Explanation>PERMANENTLY RESTRICTED NET ASSETS OF DONOR-RESTRICTED ENDOWMENT FUNDS ARE PRESERVED, ABSENT EXPLICIT DIRECTION FROM THE DONOR. PART V, LINE 1A-1G: ENDOWMENT FUNDS ARE BASED ON GAAP AND AGREE TO THE RESTRICTED FUNDS ON THE AUDITED FINANCIAL STATEMENTS.</Explanation>
      </Form990ScheduleDPartXIV>
      <Form990ScheduleDPartXIV>
        <Identifier>DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48:</Identifier>
        <ReturnReference>PART X:</ReturnReference>
        <Explanation>THE ORGANIZATION BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN, AND THEREFORE, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE CONSOLIDATED FINANCIAL STATEMENTS. AT A MINIMUM, THE 2008 THROUGH 2011 TAX YEARS ARE OPEN FOR EXAMINATION BY TAXING AUTHORITIES.</Explanation>
      </Form990ScheduleDPartXIV>
      <Form990ScheduleDPartXIV>
        <Explanation>PART IV; QUESTION 4 - INTEREST FROM THE PERMANENTLY RESTRICTED FUNDS IS INTENDED TO FUND FUTURE RESEARCH AND/OR EDUCATIONAL AWARDS.</Explanation>
      </Form990ScheduleDPartXIV>
    </IRS990ScheduleD>
    <IRS990ScheduleF documentId="RetDoc1040500001">
      <GrantRecordsMaintained>1</GrantRecordsMaintained>
      <AcctsActvsOutUSTable>
        <Region>NORTH AMERICA</Region>
        <NumberOfOffices>0</NumberOfOffices>
        <NumberOfEmployees>0</NumberOfEmployees>
        <TypeOfActivitiesConducted>GRANTS ISSUED TO INDIVIDUALS AND RECIPIENT ORGANIZATION(S), PROGRAM SERVICES</TypeOfActivitiesConducted>
        <SpecificServicesProvided>MERIT AWARDS ($21,000) AND YOUNG INVESTIGATOR AWARD ($150,000)</SpecificServicesProvided>
        <TotalExpenditures>171000</TotalExpenditures>
      </AcctsActvsOutUSTable>
      <AcctsActvsOutUSTable>
        <Region>EAST ASIA &amp; THE PACIFIC</Region>
        <NumberOfOffices>0</NumberOfOffices>
        <NumberOfEmployees>0</NumberOfEmployees>
        <TypeOfActivitiesConducted>GRANTS ISSUED TO INDIVIDUALS AND RECIPIENT ORGANIZATION(S), PROGRAM SERVICES</TypeOfActivitiesConducted>
        <SpecificServicesProvided>MERIT AWARDS ($12,000) AND YOUNG INVESTIGATOR AWARD ($50,000)</SpecificServicesProvided>
        <TotalExpenditures>60500</TotalExpenditures>
      </AcctsActvsOutUSTable>
      <AcctsActvsOutUSTable>
        <Region>EUROPE</Region>
        <NumberOfOffices>0</NumberOfOffices>
        <NumberOfEmployees>0</NumberOfEmployees>
        <TypeOfActivitiesConducted>GRANTS ISSUED TO INDIVIDUALS, PROGRAM SERVICES</TypeOfActivitiesConducted>
        <SpecificServicesProvided>MERIT AWARDS ($33,000)</SpecificServicesProvided>
        <TotalExpenditures>33000</TotalExpenditures>
      </AcctsActvsOutUSTable>
      <AcctsActvsOutUSTable>
        <Region>SOUTH AMERICA</Region>
        <NumberOfOffices>0</NumberOfOffices>
        <NumberOfEmployees>0</NumberOfEmployees>
        <TypeOfActivitiesConducted>GRANTS ISSUED TO INDIVIDUAL, PROGRAM SERVICES</TypeOfActivitiesConducted>
        <SpecificServicesProvided>MERIT AWARD ($3,000)</SpecificServicesProvided>
        <TotalExpenditures>3000</TotalExpenditures>
      </AcctsActvsOutUSTable>
      <SubtotalNumberOfOffices>0</SubtotalNumberOfOffices>
      <SubtotalNumberOfEmployees>0</SubtotalNumberOfEmployees>
      <ContNumberOfOffices>0</ContNumberOfOffices>
      <ContNumberOfEmployees>0</ContNumberOfEmployees>
      <TotalNumberOfOffices>0</TotalNumberOfOffices>
      <TotalNumberOfEmployees>0</TotalNumberOfEmployees>
      <SubtotalAmountSpent>267500</SubtotalAmountSpent>
      <ContAmountSpent>0</ContAmountSpent>
      <TotalAmountSpent>267500</TotalAmountSpent>
      <GrantsToOrgsOutsideUS>
        <Region>EAST ASIA &amp; THE PACIFIC</Region>
        <PurposeOfGrant>YOUNG INVESTIGATOR AWARD (YIA)</PurposeOfGrant>
        <AmountOfCashGrant>50000</AmountOfCashGrant>
      </GrantsToOrgsOutsideUS>
      <GrantsToOrgsOutsideUS>
        <Region>NORTH AMERICA</Region>
        <PurposeOfGrant>YOUNG INVESTIGATOR AWARD (YIA)</PurposeOfGrant>
        <AmountOfCashGrant>50000</AmountOfCashGrant>
      </GrantsToOrgsOutsideUS>
      <GrantsToOrgsOutsideUS>
        <Region>NORTH AMERICA</Region>
        <PurposeOfGrant>YOUNG INVESTIGATOR AWARD (YIA)</PurposeOfGrant>
        <AmountOfCashGrant>50000</AmountOfCashGrant>
      </GrantsToOrgsOutsideUS>
      <GrantsToOrgsOutsideUS>
        <Region>NORTH AMERICA</Region>
        <PurposeOfGrant>YOUNG INVESTIGATOR AWARD (YIA)</PurposeOfGrant>
        <AmountOfCashGrant>50000</AmountOfCashGrant>
      </GrantsToOrgsOutsideUS>
      <TotalNumberOf501c3Orgs>0</TotalNumberOf501c3Orgs>
      <TotalNumberOfOtherOrgs>4</TotalNumberOfOtherOrgs>
      <GrantsToIndOutsideUS>
        <TypeOfAssistance>AWARDS WERE GIVEN TO ONCOLOGY FELLOWS WHO ARE FIRST AUTHORS ON ABSTRACTS SELECTED FOR PRESENTATION AT AN ASCO SCIENTIFIC MEETING, INCLUDING THE ANNUAL MEETING, BREAST CANCER SYMPOSIUM, GASTROINTESTINAL CANCERS SYMPOSIUM, AND GENITOURINARY CANCERS SYMPOSIUM.</TypeOfAssistance>
        <Region>EAST ASIA &amp; PACIFIC</Region>
        <NumberOfRecipients>7</NumberOfRecipients>
        <AmountOfCashGrant>10500</AmountOfCashGrant>
      </GrantsToIndOutsideUS>
      <GrantsToIndOutsideUS>
        <TypeOfAssistance>AWARDS WERE GIVEN TO ONCOLOGY FELLOWS WHO ARE FIRST AUTHORS ON ABSTRACTS SELECTED FOR PRESENTATION AT AN ASCO SCIENTIFIC MEETING, INCLUDING THE ANNUAL MEETING, BREAST CANCER SYMPOSIUM, GASTROINTESTINAL CANCERS SYMPOSIUM, AND GENITOURINARY CANCERS SYMPOSIUM.</TypeOfAssistance>
        <Region>NORTH AMERICA</Region>
        <NumberOfRecipients>14</NumberOfRecipients>
        <AmountOfCashGrant>21000</AmountOfCashGrant>
      </GrantsToIndOutsideUS>
      <GrantsToIndOutsideUS>
        <TypeOfAssistance>AWARDS WERE GIVEN TO ONCOLOGY FELLOWS WHO ARE FIRST AUTHORS ON ABSTRACTS SELECTED FOR PRESENTATION AT AN ASCO SCIENTIFIC MEETING, INCLUDING THE ANNUAL MEETING, BREAST CANCER SYMPOSIUM, GASTROINTESTINAL CANCERS SYMPOSIUM, AND GENITOURINARY CANCERS SYMPOSIUM.</TypeOfAssistance>
        <Region>EUROPE</Region>
        <NumberOfRecipients>22</NumberOfRecipients>
        <AmountOfCashGrant>33000</AmountOfCashGrant>
      </GrantsToIndOutsideUS>
      <GrantsToIndOutsideUS>
        <TypeOfAssistance>AWARDS WERE GIVEN TO ONCOLOGY FELLOWS WHO ARE FIRST AUTHORS ON ABSTRACTS SELECTED FOR PRESENTATION AT AN ASCO SCIENTIFIC MEETING, INCLUDING THE ANNUAL MEETING, BREAST CANCER SYMPOSIUM, GASTROINTESTINAL CANCERS SYMPOSIUM, AND GENITOURINARY CANCERS SYMPOSIUM.</TypeOfAssistance>
        <Region>SOUTH AMERICA</Region>
        <NumberOfRecipients>2</NumberOfRecipients>
        <AmountOfCashGrant>3000</AmountOfCashGrant>
      </GrantsToIndOutsideUS>
      <TransferToForeignCorp>0</TransferToForeignCorp>
      <InterestInForeignTrust>0</InterestInForeignTrust>
      <OwnForeignCorp>0</OwnForeignCorp>
      <PassiveForeignInvestCo>0</PassiveForeignInvestCo>
      <ForeignPartnership>0</ForeignPartnership>
      <BoycottCountries>0</BoycottCountries>
      <Form990ScheduleFPartV>
        <Identifier>PROCEDURE FOR MONITORING GRANTS OUTSIDE THE U.S.:</Identifier>
        <Explanation>SCHEDULE F, PART I, LINE 2: CCF GRANTS ARE AWARDED BASED ON MERIT THROUGH A PEER-REVIEW PROCESS OF REVIEW CONDUCTED BY MEMBERS OF CCF'S GRANT SELECTION COMMITTEE USING ELIGIBILITY CRITERIA ESTABLISHED FOR EACH SPECIFIC GRANT. GRANTEES ARE REQUIRED TO SIGN A GRANT AGREEMENT WITH CCF THAT ESTABLISHES CERTAIN REQUIREMENTS FOR THE GRANT. GRANTEES MUST REQUEST CCF'S APPROVAL FOR ANY CHANGES IN THE GRANT PROJECT AND THE GRANTEE'S STATUS. GRANTEES MUST SUBMIT A FORMAL REQUEST FOR A CHANGE IN OBJECTIVES OR SCOPE TO CCF AND INCLUDE JUSTIFICATION FOR THE CHANGES, WHICH IS SUBJECT TO CCF'S REVIEW AND APPROVAL. GRANTEES ARE REQUIRED TO NOTIFY CCF IF THERE ARE SIGNIFICANT DELAYS THAT WILL MATERIALLY AFFECT THE ABILITY TO ATTAIN THE OBJECTIVES OF THE GRANT PROJECT OR TO MEET SUCH TIME SCHEDULES AS MAY HAVE BEEN PROPOSED. GRANTEES ARE REQUIRED TO NOTIFY CCF IF THEY PLAN TO LEAVE AN ORGANIZATION DURING THE COURSE OF A GRANT AND MUST SUBMIT A REQUEST FOR APPROVAL OF INSTITUTION TRANSFER OF THE GRANT BEFORE ANY TRANSFER TAKES PLACE. CHANGES IN THE GRANT BUDGET ARE SUBJECT TO THE REVIEW AND APPROVAL OF CCF. CCF REQUIRES TECHNICAL PROJECT REPORTS (PROGRESS REPORTS) AND BUDGET SUMMARIES (FINANCIAL REPORTS) FOR ALL GRANTS. UNLESS OTHERWISE SPECIFIED IN THE GRANT TERMS AND CONDITIONS, AN ANNUAL PROGRESS REPORT AND A BUDGET SUMMARY ARE REQUIRED TO BE SUBMITTED WITHIN 60 DAYS FOLLOWING THE END OF THE GRANT BUDGET PERIOD. CCF REVIEWS THE REPORTS AND PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. CCF REQUIRES A FINAL PROJECT REPORT AND BUDGET SUMMARY WITHIN 60 DAYS FOLLOWING EXPIRATION OF THE GRANT. CCF REVIEWS THE REPORTS AND IF APPROVED, PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. ALL UNUSED FUNDS AT THE END OF THE AWARD TERM MUST BE RETURNED TO CCF GRANTS ARE ADMINISTRATIVELY CLOSED BY CCF AFTER RECEIPT OF THE FINAL PROJECT REPORT AND FINAL BUDGET SUMMARY AND AFTER CCF'S DETERMINATION THAT ANY OTHER ADMINISTRATIVE REQUIREMENTS IN THE GRANT HAVE BEEN MET. CCF RESERVES THE RIGHT TO ASK THE GRANTEE TO RETURN FUNDS THAT WERE SPENT INCONSISTENTLY WITH THE APPROVED BUDGET.</Explanation>
      </Form990ScheduleFPartV>
      <Form990ScheduleFPartV>
        <Explanation>SCHEDULE F, PART II, LINE 1; DESCRIPTION OF AWARDS DISTRIBUTED YOUNG INVESTIGATOR AWARD (YIA) PROVIDES FUNDING TO PROMISING INVESTIATORS TO ENCOURAGE AND PROMOTE QUALITY RESEARCH IN CLINICAL ONCOLOGY. THE PURPOSE OF THIS AWARD IS TO FUND PHYSICIANS DURING THE TRANSITION FROM A FELLOWSHIP PROGRAM TO A FACULTY APPOINTMENT. TOTAL GRANT: $50,000 OVER ONE YEAR. MERIT AWARDS ARE DESIGNED TO FURTHER PROMOTE CLINICAL RESEARCH BY YOUNG SCIENTISTS AND TO PROVIDE FELLOWS WITH AN OPPORTUNITY TO PRESENT THEIR RESEARCH AND INTERACT WITH OTHER CLINICAL CANCER INVESTIGATORS AT ASCO SCIENTIFIC MEETINGS. A SELECT NUMBER OF CCF MERIT AWARDS ARE GIVEN ANNUALLY TO RECOGNIZE OUTSTANDING ABSTRACTS SUBMITTED FOR CONSIDERATION FOR PRESENTATION AT AN ASCO SCIENTIFIC MEETING. THE AWARDS ARE GIVE TO ONCOLOGY FELLOWS WHO ARE FIRST AUTHORS ON SELECTED ABSTRACTS, AND THE CRITERIA ARE DESCRIBED IN THE ELIGIBILITY AND AWARD TERMS SECTIONS.</Explanation>
      </Form990ScheduleFPartV>
    </IRS990ScheduleF>
    <IRS990ScheduleG documentId="RetDoc1041200001">
      <MailSolicitations>X</MailSolicitations>
      <EmailSolicitations>X</EmailSolicitations>
      <PhoneSolicitations>X</PhoneSolicitations>
      <InPersonSolicitations>X</InPersonSolicitations>
      <SolicitationOfNonGovtGrants>X</SolicitationOfNonGovtGrants>
      <AgreementRefFundraising>1</AgreementRefFundraising>
      <FundraiserActivityInformation>
        <NameOfIndividual>GRAHAM PELTON</NameOfIndividual>
        <AddressUS>
          <AddressLine1>39 BEACHWOOD RD</AddressLine1>
          <City>SUMMIT</City>
          <State>NJ</State>
          <ZIPCode>07901</ZIPCode>
        </AddressUS>
        <Activity>FUNDRAISING CONSULTING</Activity>
        <FundraiserControlOfFunds>0</FundraiserControlOfFunds>
        <GrossReceipts>0</GrossReceipts>
        <AmountRetainedByContractor>534850</AmountRetainedByContractor>
        <NetToOrganization>-534850</NetToOrganization>
      </FundraiserActivityInformation>
      <TotalRetainedByContractors>534850</TotalRetainedByContractors>
      <TotalNetToOrganization>-534850</TotalNetToOrganization>
      <LicensedStates>AL</LicensedStates>
      <LicensedStates>AK</LicensedStates>
      <LicensedStates>AZ</LicensedStates>
      <LicensedStates>AR</LicensedStates>
      <LicensedStates>CA</LicensedStates>
      <LicensedStates>CO</LicensedStates>
      <LicensedStates>CT</LicensedStates>
      <LicensedStates>DE</LicensedStates>
      <LicensedStates>FL</LicensedStates>
      <LicensedStates>GA</LicensedStates>
      <LicensedStates>HI</LicensedStates>
      <LicensedStates>ID</LicensedStates>
      <LicensedStates>IL</LicensedStates>
      <LicensedStates>IN</LicensedStates>
      <LicensedStates>IA</LicensedStates>
      <LicensedStates>KS</LicensedStates>
      <LicensedStates>KY</LicensedStates>
      <LicensedStates>LA</LicensedStates>
      <LicensedStates>ME</LicensedStates>
      <LicensedStates>MD</LicensedStates>
      <LicensedStates>MA</LicensedStates>
      <LicensedStates>MI</LicensedStates>
      <LicensedStates>MN</LicensedStates>
      <LicensedStates>MS</LicensedStates>
      <LicensedStates>MO</LicensedStates>
      <LicensedStates>MT</LicensedStates>
      <LicensedStates>NE</LicensedStates>
      <LicensedStates>NV</LicensedStates>
      <LicensedStates>NH</LicensedStates>
      <LicensedStates>NJ</LicensedStates>
      <LicensedStates>NM</LicensedStates>
      <LicensedStates>NY</LicensedStates>
      <LicensedStates>NC</LicensedStates>
      <LicensedStates>ND</LicensedStates>
      <LicensedStates>OH</LicensedStates>
      <LicensedStates>OK</LicensedStates>
      <LicensedStates>OR</LicensedStates>
      <LicensedStates>PA</LicensedStates>
      <LicensedStates>RI</LicensedStates>
      <LicensedStates>SC</LicensedStates>
      <LicensedStates>SD</LicensedStates>
      <LicensedStates>TN</LicensedStates>
      <LicensedStates>TX</LicensedStates>
      <LicensedStates>UT</LicensedStates>
      <LicensedStates>VT</LicensedStates>
      <LicensedStates>VA</LicensedStates>
      <LicensedStates>WA</LicensedStates>
      <LicensedStates>WV</LicensedStates>
      <LicensedStates>WI</LicensedStates>
      <LicensedStates>WY</LicensedStates>
      <Form990ScheduleGPartIV>
        <Identifier>EXPLANATION OF FUNDRAISING PAYMENTS</Identifier>
        <ReturnReference>SCHEDULE G, PART I, LINE 2B, COLUMN (V)</ReturnReference>
        <Explanation>PAYMENTS MADE TO GRAHAM PELTON CONSULTING WERE FOR FUNDRAISING GUIDANCE ON BEST PRACTICE METHODS OF EFFECTIVE AND EFFICIENT FUNDRAISING. CCF'S RELATED ORGANIZATION, AMERICAN SOCIETY OF CLINICAL ONCOLOGY, INC. (ASCO), ALSO PAID COSTS FOR FUNDRAISING SERVICES PROVIDED TO CCF, WHICH ARE REFLECTED IN THE IRS FORM 990 OF ASCO.</Explanation>
      </Form990ScheduleGPartIV>
    </IRS990ScheduleG>
    <IRS990ScheduleI documentId="RetDoc1041900001">
      <RecordsMaintained>1</RecordsMaintained>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>BAYLOR COLLEGE OF MEDICINE</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>ONE BAYLOR PLAZA</AddressLine1>
          <City>HOUSTON</City>
          <State>TX</State>
          <ZIPCode>77030</ZIPCode>
        </AddressUS>
        <EINOfRecipient>741613878</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>400000</AmountOfCashGrant>
        <PurposeOfGrant>CAREER DEVELOPMENT AWARDS</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>BENAROYA RESEARCH INSTITUTE</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>1100 NINTH AVENUE</AddressLine1>
          <City>SEATTLE</City>
          <State>WA</State>
          <ZIPCode>98101</ZIPCode>
        </AddressUS>
        <EINOfRecipient>910653422</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>50000</AmountOfCashGrant>
        <PurposeOfGrant>YOUNG INVESTIGATOR AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>CANCER CARE SPECIALISTS OF CENTRAL ILLINOIS</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>210 W MCKINLEY AVE</AddressLine1>
          <City>DECATUR</City>
          <State>IL</State>
          <ZIPCode>62521</ZIPCode>
        </AddressUS>
        <EINOfRecipient>371160364</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>30000</AmountOfCashGrant>
        <PurposeOfGrant>COMMUNITY ONCOLOGY RESEARCH GRANT</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>COLUMBIA UNIVERSITY</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>177 FT WASHINGTON AVE</AddressLine1>
          <City>NEW YORK</City>
          <State>NY</State>
          <ZIPCode>10032</ZIPCode>
        </AddressUS>
        <EINOfRecipient>131924236</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>1470000</AmountOfCashGrant>
        <PurposeOfGrant>IMPROVING CANCER CARE GRANT, YOUNG INVESTIGATOR AWARD, LOAN REPAYMENT PROGRAM</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>DANA-FARBER CANCER INSTITUTE</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>44 BINNEY STREET BP431C</AddressLine1>
          <City>BOSTON</City>
          <State>MA</State>
          <ZIPCode>02115</ZIPCode>
        </AddressUS>
        <EINOfRecipient>042263040</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>300000</AmountOfCashGrant>
        <PurposeOfGrant>YOUNG INVESTIGATOR AWARDS AND CAREER DEVELOPMENT AWARDS</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>CHILDREN'S NATIONAL MEDICAL CENTER</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>111 MICHIGAN AVE NW</AddressLine1>
          <City>WASHINGTON</City>
          <State>DC</State>
          <ZIPCode>20010</ZIPCode>
        </AddressUS>
        <EINOfRecipient>521640403</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>50000</AmountOfCashGrant>
        <PurposeOfGrant>YOUNG INVESTIGATOR AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>UNIVERSITY OF CALIFORNIA - IRVINE</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>101 THE CITY DRIVE SOUTH</AddressLine1>
          <City>ORANGE</City>
          <State>CA</State>
          <ZIPCode>92868</ZIPCode>
        </AddressUS>
        <EINOfRecipient>952321786</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>200000</AmountOfCashGrant>
        <PurposeOfGrant>CAREER DEVELOPMENT AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>JOHNS HOPKINS UNIVERSITY</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>550 NORTH BROAKWAY SUITE 1003</AddressLine1>
          <City>BALTIMORE</City>
          <State>MD</State>
          <ZIPCode>212052009</ZIPCode>
        </AddressUS>
        <EINOfRecipient>520591627</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>265000</AmountOfCashGrant>
        <PurposeOfGrant>YOUNG INVESTIGATOR AWARDS, LONG-TERM INTERNATIONAL FELLOWS</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>FLORIDA SOCIETY OF CLINICAL ONCOLOGY</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>10022 WATER WORKS LANE</AddressLine1>
          <City>RIVERVIEW</City>
          <State>FL</State>
          <ZIPCode>33578</ZIPCode>
        </AddressUS>
        <EINOfRecipient>592305471</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>10000</AmountOfCashGrant>
        <PurposeOfGrant>STATE AFFILIATE GRANT PROGRAM</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>GEORGE WASHINGTON UNIVERSITY</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>GEORGE WASHINGTON UNIVERSITY</AddressLine1>
          <City>WASHINGTON</City>
          <State>DC</State>
          <ZIPCode>20037</ZIPCode>
        </AddressUS>
        <EINOfRecipient>530196584</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>5000</AmountOfCashGrant>
        <PurposeOfGrant>MEDICAL STUDENT ROTATION AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>MEMORIAL SLOAN-KETTERING CANCER CENTER</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>GENERAL POST OFFICE BOX 263633</AddressLine1>
          <AddressLine2>THIRD AVE</AddressLine2>
          <City>NEW YORK</City>
          <State>NY</State>
          <ZIPCode>10017</ZIPCode>
        </AddressUS>
        <EINOfRecipient>131924236</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>700000</AmountOfCashGrant>
        <PurposeOfGrant>YOUNG INVESTIGATOR AWARDS, CAREER DEVELOPMENT AWARDS</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>GEORGIA SOCIETY OF CLINICAL ONCOLOGY</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>3330 CUMBERLAND BLVD</AddressLine1>
          <City>ATLANTA</City>
          <State>GA</State>
          <ZIPCode>30339</ZIPCode>
        </AddressUS>
        <EINOfRecipient>581752866</EINOfRecipient>
        <IRCSection>501 (C)(6)</IRCSection>
        <AmountOfCashGrant>10000</AmountOfCashGrant>
        <PurposeOfGrant>STATE AFFILIATE GRANT PROGRAM</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>INDIANA UNIVERSITY</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>420 UNIVERSITY BLVD</AddressLine1>
          <City>INDIANAPOLIS</City>
          <State>IN</State>
          <ZIPCode>46202</ZIPCode>
        </AddressUS>
        <EINOfRecipient>135600673</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>450000</AmountOfCashGrant>
        <PurposeOfGrant>ADVANCED CLINICAL RESEARCH AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>OHIO STATE UNIVERSITY</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>901 WOODY HAYES DR</AddressLine1>
          <City>COLUMBUS</City>
          <State>OH</State>
          <ZIPCode>43210</ZIPCode>
        </AddressUS>
        <EINOfRecipient>890330467</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>255000</AmountOfCashGrant>
        <PurposeOfGrant>YOUNG INVESTIGATOR AWARDS, MEDICAL STUDENT ROTATION AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>UNIVERSITY OF MICHIGAN</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>102 OBSERVATORY</AddressLine1>
          <City>ANN ARBOR</City>
          <State>MI</State>
          <ZIPCode>481090723</ZIPCode>
        </AddressUS>
        <EINOfRecipient>386006309</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>50000</AmountOfCashGrant>
        <PurposeOfGrant>YOUNG INVESTIGATOR AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>LINCOLN MEDICAL AND MENTAL HEALTH CENTER</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>E 149TH STREET</AddressLine1>
          <City>BRONX</City>
          <State>NY</State>
          <ZIPCode>10451</ZIPCode>
        </AddressUS>
        <EINOfRecipient>133040671</EINOfRecipient>
        <IRCSection>GOV'T ENTITY</IRCSection>
        <AmountOfCashGrant>70000</AmountOfCashGrant>
        <PurposeOfGrant>LOAN REPAYMENT PROGRAM</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>UNIVERSITY OF CALIFORNIA - SAN FRANCISCO</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>3333 CALIFORNIA STREET</AddressLine1>
          <City>SAN FRANCISCO</City>
          <State>CA</State>
          <ZIPCode>94118</ZIPCode>
        </AddressUS>
        <EINOfRecipient>942829914</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>150000</AmountOfCashGrant>
        <PurposeOfGrant>YOUNG INVESTIGATOR AWARDS</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>MAYO CLINIC</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>13400 EAST SHEA BLVD</AddressLine1>
          <City>SCOTTSDALE</City>
          <State>AZ</State>
          <ZIPCode>85259</ZIPCode>
        </AddressUS>
        <EINOfRecipient>860800150</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>200000</AmountOfCashGrant>
        <PurposeOfGrant>CAREER DEVELOPMENT AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>MEDICAL COLLEGE OF WISCONSIN</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>8701 WATERTOWN PLANK RD</AddressLine1>
          <City>MILWAUKEE</City>
          <State>WI</State>
          <ZIPCode>53226</ZIPCode>
        </AddressUS>
        <EINOfRecipient>390806261</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>50000</AmountOfCashGrant>
        <PurposeOfGrant>YOUNG INVESTIGATOR AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>MEDICAL UNIVERSITY OF SOUTH CAROLINA</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>86 JONATHAN LUCAS STREET</AddressLine1>
          <City>CHARLESTON</City>
          <State>SC</State>
          <ZIPCode>29425</ZIPCode>
        </AddressUS>
        <EINOfRecipient>576000722</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>200000</AmountOfCashGrant>
        <PurposeOfGrant>CAREER DEVELOPMENT AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>3451 WALNUT STREET</AddressLine1>
          <City>PHILADELPHIA</City>
          <State>PA</State>
          <ZIPCode>19104</ZIPCode>
        </AddressUS>
        <EINOfRecipient>231352685</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>105000</AmountOfCashGrant>
        <PurposeOfGrant>YOUNG INVESTIGATOR AWARDS, MEDICAL STUDENT ROTATION AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>PO BOX 4486</AddressLine1>
          <City>HOUSTON</City>
          <State>TX</State>
          <ZIPCode>77210</ZIPCode>
        </AddressUS>
        <EINOfRecipient>746000203</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>565000</AmountOfCashGrant>
        <PurposeOfGrant>CAREER DEVELOPMENT AWARDS, LONG-TERM INTERNATIONAL FELLOWS AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>UNIVERSITY OF CHICAGO</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>5801 SOUTH ELLIS AVENUE</AddressLine1>
          <City>CHICAGO</City>
          <State>IL</State>
          <ZIPCode>60637</ZIPCode>
        </AddressUS>
        <EINOfRecipient>362177139</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>600000</AmountOfCashGrant>
        <PurposeOfGrant>YOUNG INVESTIGATOR AWARDS, TRANSLATIONAL RESEARCH PROFESSORSHIP AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>MEHARRY MEDICAL COLLEGE</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>1005 DR D B TODD JR BLVD</AddressLine1>
          <City>NASHVILLE</City>
          <State>TN</State>
          <ZIPCode>37208</ZIPCode>
        </AddressUS>
        <EINOfRecipient>620488046</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>5000</AmountOfCashGrant>
        <PurposeOfGrant>MEDICAL STUDENT ROTATION AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>UNIVERSITY OF PITTSBURGH</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>3100 CATHEDRAL OF LEARNING</AddressLine1>
          <City>PITTSBURGH</City>
          <State>PA</State>
          <ZIPCode>15260</ZIPCode>
        </AddressUS>
        <EINOfRecipient>125096559</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>55000</AmountOfCashGrant>
        <PurposeOfGrant>YOUNG INVESTIGATOR AWARD, MEDICAL STUDENT ROTATION AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>MICHIGAN SOCIETY OF HEMATOLOGY &amp; ONCOLOGY</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>3630 ROCKINGHAM RD</AddressLine1>
          <City>ROYAL OAK</City>
          <State>MI</State>
          <ZIPCode>48073</ZIPCode>
        </AddressUS>
        <EINOfRecipient>382634114</EINOfRecipient>
        <IRCSection>501 (C)(6)</IRCSection>
        <AmountOfCashGrant>10000</AmountOfCashGrant>
        <PurposeOfGrant>STATE AFFILIATE GRANT PROGRAM</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>UNIVERSITY OF TEXAS SWESTERN</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>5323 HARRY HINES BLVD</AddressLine1>
          <City>DALLAS</City>
          <State>TX</State>
          <ZIPCode>75390</ZIPCode>
        </AddressUS>
        <EINOfRecipient>756002868</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>55000</AmountOfCashGrant>
        <PurposeOfGrant>YOUNG INVESTIGATOR AWARD, MEDICAL STUDENT ROTATION AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>NATIONAL CANCER INSTITUTE</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>NATIONAL CANCER INSTITUTE</AddressLine1>
          <City>BETHESDA</City>
          <State>MD</State>
          <ZIPCode>20892</ZIPCode>
        </AddressUS>
        <EINOfRecipient>541843091</EINOfRecipient>
        <IRCSection>GOV'T ENTITY</IRCSection>
        <AmountOfCashGrant>100000</AmountOfCashGrant>
        <PurposeOfGrant>YOUNG INVESTIGATOR AWARDS</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>VANDERBILT UNIVERSITY MEDICAL CTR</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>1640 PHOENIX BLVD SUITE 100</AddressLine1>
          <City>COLLEGE PARK</City>
          <State>GA</State>
          <ZIPCode>30349</ZIPCode>
        </AddressUS>
        <EINOfRecipient>620476822</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>50000</AmountOfCashGrant>
        <PurposeOfGrant>YOUNG INVESTIGATOR AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>WASHINGTON UNIVERSITY ST LOUIS</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>700 ROSEDALE AVE</AddressLine1>
          <City>ST LOUIS</City>
          <State>MO</State>
          <ZIPCode>63112</ZIPCode>
        </AddressUS>
        <EINOfRecipient>430653611</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>100000</AmountOfCashGrant>
        <PurposeOfGrant>YOUNG INVESTIGATOR AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>NATIONAL INSTITUTES OF HEALTH</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>33 NORTH DRIVE</AddressLine1>
          <City>BETHESDA</City>
          <State>MD</State>
          <ZIPCode>20814</ZIPCode>
        </AddressUS>
        <EINOfRecipient>530196960</EINOfRecipient>
        <IRCSection>GOV'T ENTITY</IRCSection>
        <AmountOfCashGrant>50000</AmountOfCashGrant>
        <PurposeOfGrant>YOUNG INVESTIGATOR AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>NEWARK BETH ISRAEL MEDICAL CENTER FOUNDATION</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>201 LYONS AVE</AddressLine1>
          <City>NEWARK</City>
          <State>NJ</State>
          <ZIPCode>07112</ZIPCode>
        </AddressUS>
        <EINOfRecipient>222587176</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>30000</AmountOfCashGrant>
        <PurposeOfGrant>COMMUNITY ONCOLOGY RESEARCH GRANT</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>PEDIATRIC ONCOLOGY BRANCH NATIONAL CANCER INSTITUTE</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>NATIONAL INSTITUTES OF HEALTH</AddressLine1>
          <City>BETHESDA</City>
          <State>MD</State>
          <ZIPCode>20814</ZIPCode>
        </AddressUS>
        <EINOfRecipient>520858115</EINOfRecipient>
        <IRCSection>GOV'T ENTITY</IRCSection>
        <AmountOfCashGrant>50000</AmountOfCashGrant>
        <PurposeOfGrant>YOUNG INVESTIGATOR AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>NEW MEXICO SOCIETY OF CLINICAL ONCOLOGY</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>1501 SAN PEDRO SE</AddressLine1>
          <City>ALBUQUERQUE</City>
          <State>NM</State>
          <ZIPCode>87108</ZIPCode>
        </AddressUS>
        <EINOfRecipient>850392445</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>10000</AmountOfCashGrant>
        <PurposeOfGrant>STATE AFFILIATE GRANT PROGRAM</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>ROBERT WOOD JOHNSON MEDICAL SCHOOL</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>675 HOES LANE WEST</AddressLine1>
          <City>NEW BRUNSWICK</City>
          <State>NJ</State>
          <ZIPCode>08903</ZIPCode>
        </AddressUS>
        <EINOfRecipient>521358241</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>5000</AmountOfCashGrant>
        <PurposeOfGrant>MEDICAL STUDENT ROTATION AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>TENNESSEE ONCOLOGY PRACTICE SOCIETY</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>11600 NEBEL STREET</AddressLine1>
          <City>ROCKVILLE</City>
          <State>MD</State>
          <ZIPCode>20852</ZIPCode>
        </AddressUS>
        <EINOfRecipient>621445145</EINOfRecipient>
        <IRCSection>501 (C)(6)</IRCSection>
        <AmountOfCashGrant>10000</AmountOfCashGrant>
        <PurposeOfGrant>STATE AFFILIATE GRANT PROGRAM</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>THE CHILDREN'S HOSPITAL OF PHILADELPHIA</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>34TH STREET AND CIVIC CENTER</AddressLine1>
          <City>PHILADELPHIA</City>
          <State>PA</State>
          <ZIPCode>19104</ZIPCode>
        </AddressUS>
        <EINOfRecipient>231352166</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>50000</AmountOfCashGrant>
        <PurposeOfGrant>YOUNG INVESTIGATOR AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>THE CITY COLLEGE OF NEW YORK</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>160 CONVENT AVE</AddressLine1>
          <City>NEW YORK</City>
          <State>NY</State>
          <ZIPCode>10031</ZIPCode>
        </AddressUS>
        <EINOfRecipient>135598093</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>5000</AmountOfCashGrant>
        <PurposeOfGrant>MEDICAL STUDENT ROTATION AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>MASSACHUSETTS GENERAL HOSPITAL</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>555 FRUIT STREET</AddressLine1>
          <City>BOSTON</City>
          <State>MA</State>
          <ZIPCode>02114</ZIPCode>
        </AddressUS>
        <EINOfRecipient>041564655</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>200000</AmountOfCashGrant>
        <PurposeOfGrant>CAREER DEVELOPMENT AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>THE VALLEY HOSPITAL</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>223 N VAN DIEN AVE</AddressLine1>
          <City>RIDGEWOOD</City>
          <State>NJ</State>
          <ZIPCode>07450</ZIPCode>
        </AddressUS>
        <EINOfRecipient>221487397</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>30000</AmountOfCashGrant>
        <PurposeOfGrant>COMMUNITY ONCOLOGY RESEARCH GRANT</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>UNIVERSITY OF ALABAMA AT BIRMINGHAM</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>1802 SIXTH AVE SOUTH</AddressLine1>
          <City>BIRMINGHAM</City>
          <State>AL</State>
          <ZIPCode>35294</ZIPCode>
        </AddressUS>
        <EINOfRecipient>636005396</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>50000</AmountOfCashGrant>
        <PurposeOfGrant>YOUNG INVESTIGATOR AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>UNIVERSITY OF MARYLAND</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>22 SOUTH GREENE STREET</AddressLine1>
          <City>BALTIMORE</City>
          <State>MD</State>
          <ZIPCode>21201</ZIPCode>
        </AddressUS>
        <EINOfRecipient>521362753</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>70000</AmountOfCashGrant>
        <PurposeOfGrant>LOAN REPAYMENT PROGRAM</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>1601 NORTHWEST 12TH AVE</AddressLine1>
          <City>MIAMI</City>
          <State>FL</State>
          <ZIPCode>33136</ZIPCode>
        </AddressUS>
        <EINOfRecipient>590624458</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>50000</AmountOfCashGrant>
        <PurposeOfGrant>YOUNG INVESTIGATOR AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>UNIVERSITY OF WISCONSIN</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>600 HIGHLAND AVE</AddressLine1>
          <City>MADISON</City>
          <State>WI</State>
          <ZIPCode>53792</ZIPCode>
        </AddressUS>
        <EINOfRecipient>396006492</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>50000</AmountOfCashGrant>
        <PurposeOfGrant>YOUNG INVESTIGATOR AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>WEST VIRGINIA UNIVERSITY</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>PO BOX 9100</AddressLine1>
          <City>MORGANTOWN</City>
          <State>WV</State>
          <ZIPCode>26506</ZIPCode>
        </AddressUS>
        <EINOfRecipient>556000842</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>200000</AmountOfCashGrant>
        <PurposeOfGrant>CAREER DEVELOPMENT AWARD</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>YOLANDA G BARCO ONCOLOGY INSTITUTE</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>751 LIBERTY STREET</AddressLine1>
          <City>MEADVILLE</City>
          <State>PA</State>
          <ZIPCode>16335</ZIPCode>
        </AddressUS>
        <EINOfRecipient>251512436</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>70000</AmountOfCashGrant>
        <PurposeOfGrant>LOAN REPAYMENT PROGRAM</PurposeOfGrant>
      </RecipientTable>
      <RecipientTable>
        <RecipientNameBusiness>
          <BusinessNameLine1>AMERICAN SOCIETY OF CLINICAL ONCOLOGY</BusinessNameLine1>
        </RecipientNameBusiness>
        <AddressUS>
          <AddressLine1>2318 MILL RD 800</AddressLine1>
          <City>ALEXANDRIA</City>
          <State>VA</State>
          <ZIPCode>22314</ZIPCode>
        </AddressUS>
        <EINOfRecipient>136180380</EINOfRecipient>
        <IRCSection>501 (C)(3)</IRCSection>
        <AmountOfCashGrant>7731584</AmountOfCashGrant>
        <PurposeOfGrant>CONTRIBUTION</PurposeOfGrant>
      </RecipientTable>
      <TotalNbrOf501C3AndGovtGrants>44</TotalNbrOf501C3AndGovtGrants>
      <TotalNbrOfOtherOrganizations>3</TotalNbrOfOtherOrganizations>
      <Form990ScheduleIPartIII>
        <TypeOfGrant>ONCOLOGY TRAINEE TRAVEL AWARDS ALLOW FOR THE SUPPORT OF CONTINUING EDUCATION AND PROFESSIONAL DEVELOPMENT OF TRAINEE ONCOLOGISTS BY PROVIDING THEM INDIVIDUAL TRAVEL GRANT TO DEFRAY TRAVEL EXPENSES FOR ATTENDING THE ASCO ANNUAL MEETING.</TypeOfGrant>
        <NumberOfRecipients>103</NumberOfRecipients>
        <AmountOfCashGrant>244000</AmountOfCashGrant>
      </Form990ScheduleIPartIII>
      <Form990ScheduleIPartIII>
        <TypeOfGrant>MERIT AWARDS WERE GIVEN TO ONCOLOGY FELLOWS, WHO ARE FIRST AUTHORS ON RESEARCH REFLECTED IN ABSTRACTS SELECTED FOR PRESENTATION AT AN ASCO SCIENTIFIC MEETING.</TypeOfGrant>
        <NumberOfRecipients>172</NumberOfRecipients>
        <AmountOfCashGrant>223000</AmountOfCashGrant>
      </Form990ScheduleIPartIII>
      <Form990ScheduleIPartIII>
        <TypeOfGrant>GIANNI BONADONNA BREAST CANCER AWARD</TypeOfGrant>
        <NumberOfRecipients>2</NumberOfRecipients>
        <AmountOfCashGrant>60000</AmountOfCashGrant>
      </Form990ScheduleIPartIII>
      <Form990ScheduleIPartIII>
        <TypeOfGrant>PATIENT ADVOCATE SCHOLARSHIP WERE PROVIDED FOR ADVOCATES TO ATTEND THE SCIENTIFIC AND EDUCATIONAL SESSIONS AT THE ASCO ANNUAL MEETING AND BREAST CANCER SYMPOSIUM.</TypeOfGrant>
        <NumberOfRecipients>61</NumberOfRecipients>
        <AmountOfCashGrant>99669</AmountOfCashGrant>
      </Form990ScheduleIPartIII>
      <Form990ScheduleIPartIV>
        <Identifier>PROCEDURE FOR MONITORING GRANTS IN THE U.S.:</Identifier>
        <ReturnReference>PART I, LINE 2:</ReturnReference>
        <Explanation>SCHEDULE I, PART I, LINE 2: CCF GRANTS SEVERAL SPECIAL AWARDS INTENDED TO RECOGNIZE AND ENCOURAGE INDIVIDUALS OR ORGANIZATIONS WHOSE COMMITMENT TO FURTHERING THE PROGRESS AGAINST CANCER HAS LED TO TREMENDOUS CONTRIBUTIONS TO THE FIELD OF CLINICAL ONCOLOGY, CANCER PATIENTS, AND ASCO, ITS RELATED ORGANIZATION. SPECIAL AWARD RECIPIENTS ARE HONORED AT AND MOST GIVE A LECTURE DURING AN ASCO MEETING OR SYMPOSIUM. SPECIAL AWARD RECIPIENTS ARE SELECTED BASED ON A PEER-REVIEW PROCESS USING ELIGIBILITY CRITERIA ESTABLISHED FOR EACH AWARD. FUNDS AWARDED TO SPECIAL AWARD RECIPIENTS ARE GIVEN AS STIPENDS OR PRIZES, NOT FOR SPECIFIC RESEARCH PROJECTS THAT ARE SUBJECT TO REPORTING. DUE TO THE TYPE OF AWARD THERE IS NO FOLLOW UP ON THE USE OF THE FUNDS. THE GIANNI BONADONNA BREAST CANCER AWARD RECIPIENTS ARE REQUIRED TO NOTIFY GRANT SUPPORT STAFF IF THERE ARE SIGNIFICANT DELAYS THAT WILL MATERIALLY AFFECT THE ABILITY TO ATTAIN THE OBJECTIVES OF THE GRANT PROJECT OR TO MEET SUCH TIME SCHEDULES AS MAY HAVE BEEN PROPOSED. GRANTEES ARE REQUIRED TO NOTIFY THE GRANT SUPPORT STAFF IF THEY PLAN TO LEAVE AN ORGANIZATION DURING THE COURSE OF A GRANT AND MUST SUBMIT A REQUEST FOR APPROVAL OF INSTITUTION TRANSFER OF THE GRANT BEFORE ANY TRANSFER TAKES PLACE. THE GRANT SUPPORT STAFF REQUIRES TECHNICAL PROJECT REPORTS (PROGRESS REPORTS) AND BUDGET SUMMARIES (FINANCIAL REPORTS) FOR ALL GRANTS. UNLESS OTHERWISE SPECIFIED IN THE GRANT TERMS AND CONDITIONS, AN ANNUAL PROGRESS REPORT AND A BUDGET SUMMARY ARE REQUIRED TO BE SUBMITTED WITHIN 30 DAYS FOLLOWING THE END OF THE GRANT BUDGET PERIOD. THE GRANT SUPPORT STAFF REVIEWS THE REPORTS AND PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. THE GRANT SUPPORT STAFF REQUIRES A FINAL PROJECT REPORT AND BUDGET SUMMARY WITHIN 30 DAYS FOLLOWING EXPIRATION OF THE GRANT. THE GRANT SUPPORT STAFF REVIEWS THE REPORTS AND IF APPROVED, PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. ALL UNUSED FUNDS AT THE END OF THE AWARD TERM MUST BE RETURNED. GRANTS ARE ADMINISTRATIVELY CLOSED BY THE GRANT SUPPORT STAFF AFTER RECEIPT OF THE FINAL PROJECT REPORT AND FINAL BUDGET SUMMARY AND AFTER THE GRANT SUPPORT STAFF'S DETERMINATION THAT ANY OTHER ADMINISTRATIVE REQUIREMENTS IN THE GRANT HAVE BEEN MET. THE GRANT SUPPORT STAFF RESERVES THE RIGHT TO ASK THE GRANTEE TO RETURN FUNDS THAT WERE SPENT INCONSISTENTLY WITH THE APPROVED BUDGET. ADVANCED CLINICAL RESEARCH AWARD (ACRA) IS DESIGNED FOR CLINICAL ONCOLOGY RESEARCHERS INVOLVED IN INVESTIGATIVE WORK FOR 5-10 YEARS AND INTENDED TO SUPPORT ORIGINAL RESEARCH NOT CURRENTLY FUNDED. TOTAL GRANT: $450,000 OVER THREE YEARS. TRANSLATIONAL RESEARCH PROFESSORSHIP AWARD (TRP) IS INTENDED TO SUPPORT QUALIFIED RESEARCHERS WHO ARE DEDICATED TO BRINGING ADVANCES IN BASIC SCIENCES INTO THE CLINICAL ARENA AND TO MENTORING OTHER TRANSLATIONAL RESEARCHERS. TOTAL GRANT: $300,000 OVER THREE YEARS. CAREER DEVELOPMENT AWARD (CDA) PROVIDES FUNDING TO CLINICAL INVESTIGATORS WHO HAVE RECEIVED THEIR INITIAL FACULTY APPOINTMENT TO ESTABLISH AN INDEPENDENT CLINICAL CANCER RESEARCH PROGRAM. TOTAL GRANT: $200,000 OVER THREE YEARS. GIANNI BONADONNA BREAST CANCER AWARD AND FELLOWSHIP RECOGNIZES AN ACTIVE CLINICAL OR TRANSLATIONAL RESEARCHER WITH A DISTINGUISHED RECORD OF ACCOMPLISHMENTS IN ADVANCING THE FIELD OF BREAST CANCER. THE RECIPIENT RECEIVES A $10,000 AWARD AND DELIVERS A LECTURE DURING THE BREAST CANCER SYMPOSIUM. THE AWARD IS ACCOMPANIED BY A ONE-YEAR $50,000 FELLOWSHIP AWARD TO AN EARLY-CAREER BREAST CANCER RESEARCHER AT THE AWARD RECIPIENT'S AFFILIATED INSTITUTION. THE FELLOWSHIP AWARD WILL FUND AN INVESTIGATOR WHOSE BREAST CANCER RESEARCH HAS A PATIENT-ORIENTED FOCUS, INCLUDING CLINICAL TRIALS OR TRANSLATIONAL RESEARCH INVOLVING HUMAN PARTICIPANTS. YOUNG INVESTIGATOR AWARD (YIA) PROVIDES FUNDING TO PROMISING INVESTIATORS TO ENCOURAGE AND PROMOTE QUALITY RESEARCH IN CLINICAL ONCOLOGY. THE PURPOSE OF THIS AWARD IS TO FUND PHYSICIANS DURING THE TRANSITION FROM A FELLOWSHIP PROGRAM TO A FACULTY APPOINTMENT. TOTAL GRANT: $50,000 OVER ONE YEAR. IMPROVING CANCER CARE GRANT (ICCG), FUNDED BY SUSAN G. KOMEN FOR THE CURE(R), PROVIDES EXTRAMURAL RESEARCH FUNDING TO ADDRESS IMPORTANT ISSUES REGARDING ACCESS TO HEALTHCARE, QUALITY OF CARE, AND DELIVERY OF CARE, WITH GENERAL APPLICABILITY TO BREAST CANCER. THE GOAL OF THIS PROGRAM IS TO ENCOURAGE MULTI-DISCIPLINARY RESEARCH THAT WILL HAVE A MAJOR IMPACT ON CANCER CARE, WITH GENERAL APPLICABILITY IN THE BREAST CANCER ARENA. TOTAL GRANT: $1,350,000 OVER THREE YEARS. COMMUNITY ONCOLOGY RESEARCH GRANT (CORG)IS GIVEN TO COMMUNITY-BASED PRACTICES TO SUPPORT THEIR EFFORTS TO ENHANCE THEIR CLINICAL TRIALS PROGRAM. AREAS OF IMPROVEMENT ARE BASED ON THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY STATEMENT OF MINIMUM STANDARDS AND EXEMPLARY ATTRIBUTES OF CLINICAL TRIAL SITES (JOURNAL OF CLINICAL ONCOLOGY, MAY 20 2008). TOTAL GRANT: $30,000 OVER ONE YEAR. STATE AFFILIATE GRANT PROGRAM (SAGP)- THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY CREATED THE STATE AFFILIATED GRANT PROGRAM IN 2005 TO PROVIDE FINANCIAL SUPPORT TO ITS STATE/REGIONAL AFFILIATES AS THEY SEEK TO ENHANCE THE SCOPE OF THEIR ACTIVITIES. ALL 48 AFFILIATES ARE ELIGIBLE TO APPLY FOR A GRANT. IN 2011, CCF PROVIDED $50,000 TO FIVE STATE SOCIETIES TO ENGAGE IN PROJECTS THAT WILL HAVE AN OVERALL BENEFIT TO THEIR MEMBERS, ASCO MEMBERS, OTHER STATE SOCIETIES AND THE GENERAL ONCOLOGY COMMUNITY. MERIT AWARDS ARE DESIGNED TO FURTHER PROMOTE CLINICAL RESEARCH BY YOUNG SCIENTISTS AND TO PROVIDE FELLOWS WITH AN OPPORTUNITY TO PRESENT THEIR RESEARCH AND INTERACT WITH OTHER CLINICAL CANCER INVESTIGATORS AT ASCO SCIENTIFIC MEETINGS. A SELECT NUMBER OF CCF MERIT AWARDS ARE GIVEN ANNUALLY TO RECOGNIZE OUTSTANDING ABSTRACTS SUBMITTED FOR CONSIDERATION FOR PRESENTATION AT AN ASCO SCIENTIFIC MEETING. THE AWARDS ARE GIVE TO ONCOLOGY FELLOWS WHO ARE FIRST AUTHORS ON SELECTED ABSTRACTS, AND THE CRITERIA ARE DESCRIBED IN THE ELIGIBILITY AND AWARD TERMS SECTIONS. CLINICAL TRIALS PARTICIPATION AWARD (CTPA)- INTENDED TO INCREASE AWARENESS AND PARTICIPATION IN CLINICAL TRIALS AMOUNG PHYSICIANS. NOMINATIONS ARE REQUESTED FROM THE ASCO CLINICAL PRACTICE COMMITTEE, COMMUNITY CLINICAL ONCOLOGY PROGRAM, EACH OF THE NCI COOPERATIVE GROUPS, AND VARIOUS COMMUNITY-BASED ONCOLOGY RESEARCH NETWORKS. CCF PROVIDES THE FUNDING FOR THE INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD (IDEA). THE IDEA IS PROVIDED TO ONCOLOGISTS IN DEVELOPING COUNTRIES TO LEARN ABOUT ONCOLOGY AT THE ASCO ANNUAL MEETING, AT A CANCER CENTER, AND TO DEVELOP LONG-TERM RELATIONSHIPS TO IMPROVE CANCER CARE IN THEIR COUNTRIES. LONG-TERM INTERNATIONAL FELLOWSHIP (LIFE) PROVIDES EARLY-CAREER ONCOLOGISTS IN DEVELOPING NATIONS THE SUPPORT AND RESOURCES NEEDED TO ADVANCE THEIR TRAINING BY DEEPENING THEIR RELATIONSHIP WITH A UNITED STATES OR CANADIAN COLLEAGUE AND HIS OR HER INSTITUTION. THROUGH A ONE OR TWO YEAR FELLOWSHIP, THE RECIPIENT WILL EARN VALUABLE TRAINING AND EXPERIENCE WITH WHICH THEY CAN AFFECT CHANGE IN CANCER CARE IN THEIR HOME COUNTRY. RECIPIENTS MUST RETURN TO THEIR HOME INSTITUTIONS AFTER COMPLETING THEIR FELLOWSHIP AND ARE EXPECTED TO DISSEMINATE THE KNOWLEDGE THEY HAVE GAINED. ONCOLOGY TRAINEE TRAVEL AWARDS (OTTA) ALLOW FOR THE SUPPORT OF CONTINUING EDUCATION AND PROFESSIONAL DEVELOPMENT OF TRAINEE ONCOLOGISTS FROM THE UNITED STATES AND CANADA, BY PROVIDING THEM INDIVIDUAL TRAVEL GRANTS TO DEFRAY TRAVEL EXPENSES FOR ATTENDING THE ASCO ANNUAL MEETING. LOAN REPAYMENT PROGRAM- THE ASCO LOAN REPAYMENT PROGRAM (LRP), FUNDED BY SUSAN G. KOMEN FOR THE CURE(R), PROVIDES REPAYMENT OF QUALIFYING EDUCATIONAL DEBT TO ONCOLOGISTS, OR TO ONCOLOGY FELLOWS UPON COMPLETION OF TRAINING, WHO COMMIT TO PRACTICING ONCOLOGY IN A MEDICALLY UNDERSERVED REGION OF THE UNITED STATES. MEDICAL STUDENT ROTATION (MSR)- THE ASCO MEDICAL STUDENT ROTATION, FUNDED BY SUSAN G. KOMEN FOR THE CURE(R), PROVIDES 8- TO 10-WEEK CLINICAL OR CLINICAL RESEARCH ONCOLOGY ROTATIONS FOR U.S. MEDICAL STUDENTS FROM POPULATIONS UNDERREPRESENTED IN MEDICINE WHO ARE INTERESTED IN PURSUING ONCOLOGY AS A CAREER.</Explanation>
      </Form990ScheduleIPartIV>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="RetDoc1042400001">
      <SeverancePayment>0</SeverancePayment>
      <SupplementalNonqualRetirePlan>0</SupplementalNonqualRetirePlan>
      <EquityBasedCompArrangement>0</EquityBasedCompArrangement>
      <CompBasedOnRevenueOfFilingOrg>0</CompBasedOnRevenueOfFilingOrg>
      <CompBasedOnRevenueRelatedOrgs>0</CompBasedOnRevenueRelatedOrgs>
      <CompBasedNetEarningsFilingOrg>0</CompBasedNetEarningsFilingOrg>
      <CompBasedNetEarningsRelateOrgs>0</CompBasedNetEarningsRelateOrgs>
      <AnyNonFixedPayments>0</AnyNonFixedPayments>
      <InitialContractException>0</InitialContractException>
      <Form990ScheduleJPartII>
        <NamePerson>ALLEN LICHTER MD</NamePerson>
        <BaseCompensationFilingOrg>0</BaseCompensationFilingOrg>
        <CompBasedOnRelatedOrgs>666323</CompBasedOnRelatedOrgs>
        <BonusFilingOrg>0</BonusFilingOrg>
        <BonusRelatedOrgs>67571</BonusRelatedOrgs>
        <OtherCompensationFilingOrg>0</OtherCompensationFilingOrg>
        <OtherCompensationRelatedOrgs>15000</OtherCompensationRelatedOrgs>
        <DeferredCompFilingOrg>0</DeferredCompFilingOrg>
        <DeferredCompRelatedOrgs>18375</DeferredCompRelatedOrgs>
        <NontaxableBenefitsFilingOrg>0</NontaxableBenefitsFilingOrg>
        <NontaxableBenefitsRelatedOrgs>1787</NontaxableBenefitsRelatedOrgs>
        <TotalCompensationFilingOrg>0</TotalCompensationFilingOrg>
        <TotalCompensationRelatedOrgs>769056</TotalCompensationRelatedOrgs>
        <CompReportPrior990FilingOrg>0</CompReportPrior990FilingOrg>
        <CompReportPrior990RelatedOrgs>0</CompReportPrior990RelatedOrgs>
      </Form990ScheduleJPartII>
      <Form990ScheduleJPartII>
        <NamePerson>NANCY DALY MS MPH</NamePerson>
        <BaseCompensationFilingOrg>0</BaseCompensationFilingOrg>
        <CompBasedOnRelatedOrgs>199675</CompBasedOnRelatedOrgs>
        <BonusFilingOrg>0</BonusFilingOrg>
        <BonusRelatedOrgs>10849</BonusRelatedOrgs>
        <OtherCompensationFilingOrg>0</OtherCompensationFilingOrg>
        <OtherCompensationRelatedOrgs>0</OtherCompensationRelatedOrgs>
        <DeferredCompFilingOrg>0</DeferredCompFilingOrg>
        <DeferredCompRelatedOrgs>11722</DeferredCompRelatedOrgs>
        <NontaxableBenefitsFilingOrg>0</NontaxableBenefitsFilingOrg>
        <NontaxableBenefitsRelatedOrgs>12209</NontaxableBenefitsRelatedOrgs>
        <TotalCompensationFilingOrg>0</TotalCompensationFilingOrg>
        <TotalCompensationRelatedOrgs>234455</TotalCompensationRelatedOrgs>
        <CompReportPrior990FilingOrg>0</CompReportPrior990FilingOrg>
        <CompReportPrior990RelatedOrgs>0</CompReportPrior990RelatedOrgs>
      </Form990ScheduleJPartII>
      <Form990ScheduleJPartII>
        <NamePerson>DINA MICHELS ESQ</NamePerson>
        <BaseCompensationFilingOrg>0</BaseCompensationFilingOrg>
        <CompBasedOnRelatedOrgs>468167</CompBasedOnRelatedOrgs>
        <BonusFilingOrg>0</BonusFilingOrg>
        <BonusRelatedOrgs>0</BonusRelatedOrgs>
        <OtherCompensationFilingOrg>0</OtherCompensationFilingOrg>
        <OtherCompensationRelatedOrgs>0</OtherCompensationRelatedOrgs>
        <DeferredCompFilingOrg>0</DeferredCompFilingOrg>
        <DeferredCompRelatedOrgs>18375</DeferredCompRelatedOrgs>
        <NontaxableBenefitsFilingOrg>0</NontaxableBenefitsFilingOrg>
        <NontaxableBenefitsRelatedOrgs>15692</NontaxableBenefitsRelatedOrgs>
        <TotalCompensationFilingOrg>0</TotalCompensationFilingOrg>
        <TotalCompensationRelatedOrgs>502234</TotalCompensationRelatedOrgs>
        <CompReportPrior990FilingOrg>0</CompReportPrior990FilingOrg>
        <CompReportPrior990RelatedOrgs>0</CompReportPrior990RelatedOrgs>
      </Form990ScheduleJPartII>
      <Form990ScheduleJPartII>
        <NamePerson>PAUL AINES CPA</NamePerson>
        <BaseCompensationFilingOrg>0</BaseCompensationFilingOrg>
        <CompBasedOnRelatedOrgs>282362</CompBasedOnRelatedOrgs>
        <BonusFilingOrg>0</BonusFilingOrg>
        <BonusRelatedOrgs>5000</BonusRelatedOrgs>
        <OtherCompensationFilingOrg>0</OtherCompensationFilingOrg>
        <OtherCompensationRelatedOrgs>0</OtherCompensationRelatedOrgs>
        <DeferredCompFilingOrg>0</DeferredCompFilingOrg>
        <DeferredCompRelatedOrgs>16442</DeferredCompRelatedOrgs>
        <NontaxableBenefitsFilingOrg>0</NontaxableBenefitsFilingOrg>
        <NontaxableBenefitsRelatedOrgs>16509</NontaxableBenefitsRelatedOrgs>
        <TotalCompensationFilingOrg>0</TotalCompensationFilingOrg>
        <TotalCompensationRelatedOrgs>320313</TotalCompensationRelatedOrgs>
        <CompReportPrior990FilingOrg>0</CompReportPrior990FilingOrg>
        <CompReportPrior990RelatedOrgs>0</CompReportPrior990RelatedOrgs>
      </Form990ScheduleJPartII>
    </IRS990ScheduleJ>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION A, LINE 1</ReturnReference>
        <Explanation>AS OF DECEMBER 31, 2011, THE BOARD OF DIRECTORS OF CCF INCLUDED TWELVE (12) DIRECTORS WITH VOTING RIGHTS AND TWO (2) DIRECTORS WITHOUT VOTING RIGHTS. ELEVEN (11) DIRECTORS WITH VOTING RIGHTS WERE APPOINTED BY THE BOARD OF DIRECTORS OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, INC. (ASCO) A NON-PROFIT, 501(C)(3) TAX EXEMPT ORGANIZATION, A RELATED ORGANIZATION. THERE WERE THREE EX OFFICIO DIRECTORS: THE CHIEF EXECUTIVE OFFICER (WITH VOTING RIGHTS), THE ASCO PRESIDENT (WITHOUT VOTING RIGHTS) AND THE EXECUTIVE DIRECTOR (WITHOUT VOTING RIGHTS). ALL VOTING MEMBERS OF THE BOARD OF DIRECTORS HAVE THE SAME VOTING RIGHTS. CONSISTENT WITH CCF'S BYLAWS, DURING THE REPORTED TAX YEAR, THE BOARD OF DIRECTORS DELEGATED AUTHORITY TO THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS. THE EXECUTIVE COMMITTEE IS COMPOSED OF THE CHAIR, CEO, SECRETARY, TREASURER, AND A FIFTH EXECUTIVE COMMITTEE MEMBER ELECTED BY THE DIRECTORS. ALL EXECUTIVE COMMITTEE MEMBERS ARE MEMBERS OF CCF'S BOARD OF DIRECTORS. THE SCOPE OF THE EXECUTIVE COMMITTEE'S AUTHORITY IS ESTABLISHED BY CCF'S BYLAWS, WHICH PROVIDE THAT EXCEPT TO THE EXTENT SPECIFICALLY PROHIBITED BY RESOLUTION OF THE BOARD OF DIRECTORS OR OTHERWISE PROHIBITED BY LAW AND EXCEPTED AS SPECIFIED IN THE BYLAWS, THE EXECUTIVE COMMITTEE OF THE BOARD IS EMPOWERED TO MAKE AND IMPLEMENT DECIDIONS BETWEEN BOARD MEETINGS AND IT MAY ACT ON ITEMS REQUIRING ACTION PRIOR TO THE NEXT ANNOUNCED BOARD MEETING. ACTIONS OF THE EXECUTIVE COMMITTEE ARE REPORTED TO THE BOARD OF DIRECTORS AT THE MEETING OF THE BOARD OF DIRECTORS IMMEDIATELY FOLLOWING THE ACTION TAKEN BY THE EXECUTIVE COMMITTEE, CONSISTENT WITH CCF'S BYLAWS.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION A, LINE 1</ReturnReference>
        <Explanation>ONE VOTING MEMBER OF CCF'S BOARD OF DIRECTORS DOES NOT MEET THE DEFINITIONAL TEST OF AN INDEPENDENT MEMBER OF CCF'S GOVERNING BODY: ALLEN LICHTER, M.D. IS AN EX-OFFICIO, VOTING MEMBER OF CCF'S BOARD OF DIRECTORS WHO SERVES AS THE CEO OF CCF AND THE CEO OF ASCO (A RELATED ORGANIZATION OF CCF). HE IS AN EMPLOYEE OF ASCO AND RECEIVED COMPENSATION FROM ASCO.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION A, LINE 4</ReturnReference>
        <Explanation>DURING THE REPORTED TAX YEAR, CCF AMENDED ITS ARTICLES OF INCORPORATION TO ADD THE ASCO PRESIDENT AS AN EX-OFFICIO, NON-VOTING MEMBER OF ITS BOARD OF DIRECTORS.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION A, LINE 7A</ReturnReference>
        <Explanation>CCF DOES NOT HAVE MEMBERS. DIRECTORS OF CCF ARE APPOINTED AND SUBJECT TO REMOVAL BY THE BOARD OF DIRECTORS OF ASCO, EXCEPT FOR DIRECTORS SERVING EX-OFFICIO.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION A, LINE 7B</ReturnReference>
        <Explanation>THE BOARD OF DIRECTORS OF CCF MAY VOTE TO AMEND OR REPEAL THE BYLAWS OF CCF, BUT THE BOARD OF DIRECTORS OF ASCO MUST APPROVE AN AMENDMENT OR REPEAL OF THE BYLAWS TO BE EFFECTIVE.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION B, LINE 11</ReturnReference>
        <Explanation>AN ELECTRONIC COPY OF THE CCF FORM 990 WAS SENT, THROUGH A SECURE SITE, TO EACH MEMBER OF THE CCF FINANCE COMMITTEE AND WAS DISCUSSED AT A MEETING OF THE FINANCE COMMITTEE BEFORE IT WAS FILED. AN ELECTRONIC COPY OF THE CCF FORM 990 WAS SENT, THROUGH A SECURE SITE, TO EACH MEMBER OF THE BOARD OF DIRECTORS BEFORE IT WAS FILED. THE CCF FORM 990 WAS REVIEWED BY THE CHIEF FINANCIAL OFFICER, THE EXECUTIVE DIRECTOR, THE CHIEF EXECUTIVE OFFICER, AND THE GENERAL COUNSEL PRIOR TO FILING.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION B, LINE 12C</ReturnReference>
        <Explanation>CCF MAINTAINS A NUMBER OF WRITTEN CONFLICT OF INTEREST POLICIES AND STANDARDS REGARDING THE DISCLOSURE AND MANAGEMENT OF CONFLICTS OF INTEREST. THESE POLICIES AND STANDARDS COVER ALL CCF STAFF, DIRECTORS, OFFICERS, COMMITTEE MEMBERS, AND ANY PERSON IN A RELATIONSHIP WITH THESE INDIVIDUALS INVOLVING THE SHARING OF INCOME OR ASSETS (E.G., SPOUSE, DEPENDENT CHILDREN). UNDER CCF'S POLICIES, COVERED INDIVIDUALS ARE ASKED TO DISCLOSE FINANCIAL INTERESTS IN OR OTHER RELATIONSHIPS WITH ENTITIES THAT HAVE RELEVANT COMMERCIAL INTERESTS, INCLUDING EMPLOYMENT OR LEADERSHIP POSITIONS, CONSULTANT OR ADVISORY ROLES, STOCK OWNERSHIP, HONORARIA, RESEARCH FUNDING, AND SERVICE AS AN EXPERT WITNESS. COMPLETION OF A DISCLOSURE FORM IS REQUIRED AT THE INITIATION OF SERVICE, AND UPDATED ANNUALLY THEREAFTER OR WHEN ANY MATERIAL CHANGES OCCUR. CCF'S CONFLICT OF INTEREST POLICIES ARE INTENDED TO HELP GUIDE THE MANAGEMENT OF ACTUAL, POTENTIAL, AND PERCEIVED CONFLICTS OF INTEREST THROUGH DISCLOSURE OF FINANCIAL INTERESTS OR OTHER RELATIONSHIPS. WHERE THE NATURE AND EXTENT OF A FINANCIAL RELATIONSHIP SUGGEST DISCLOSURE IS NOT ADEQUATE TO MANAGE A REAL OR POTENTIAL CONFLICT, COVERED INDIVIDUALS ARE REQUIRED TO RECUSE THEMSELVES FROM DECISION MAKING. RECUSAL MAY BE SELF-SELECTED, OR MAY BE REQUESTED BY THE COMMITTEE CHAIR, OFFICER, OR EXECUTIVE-LEVEL STAFF MEMBERS. IN ADDITION, WHEN CCF IS CONTEMPLATING ENTERING INTO A TRANSACTION OR ARRANGEMENT THAT MIGHT BENEFIT THE PRIVATE INTEREST OF ANY "INTERESTED PERSON" (I.E., A CCF DIRECTOR, PRINCIPAL OFFICER, OR MEMBER OF A COMMITTEE WITH BOARD DELEGATED POWERS WHO HAS A DIRECT OR INDIRECT FINANCIAL INTEREST IN THE TRANSACTION), IT MUST FOLLOW A SPECIFIC PROCEDURE TO MANAGE THE CONFLICT, INCLUDING CONSIDERING ALTERNATIVE TRANSACTIONS THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION B, LINE 15</ReturnReference>
        <Explanation>THE FOLLOWING EMPLOYEES OF ASCO SERVE AS OFFICERS OF CCF. INFORMATION REGARDING THEIR COMPENSATION AND THE PROCESS FOR DETERMINING THEIR COMPENSATION ARE DESCRIBED IN THE IRS FORM 990 OF ASCO: CEO OF CCF (ALSO SERVES AS CEO OF ASCO) EXECUTIVE DIRECTOR OF CCF CFO OF CCF (ALSO SERVES AS CFO OF ASCO) GENERAL COUNSEL OF CCF (ALSO SERVES AS VP/GENERAL COUNSEL OF ASCO) CCF STAFF ARE EMPLOYEES OF ASCO WHO ARE LEASED TO CCF. APPLICABLE INFORMATION REGARDING THEIR COMPENSATION IS DESCRIBED IN THE IRS FORM 990 OF ASCO.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART VI, SECTION C, LINE 19</ReturnReference>
        <Explanation>CCF'S GOVERNING DOCUMENTS ARE AVAILABLE TO THE PUBLIC FROM CCF UPON REQUEST. CCF'S ARTICLES OF INCORPORATION ARE ALSO AVAILABLE TO THE PUBLIC THROUGH THE VIRGINIA STATE CORPORATION COMMISSION. CONFLICT OF INTEREST POLICIES AND STANDARDS ARE POSTED ON CCF'S WEBSITE. THE ANNUAL REPORT OF CCF IS POSTED ON CCF'S WEBSITE AND IS AVAILABLE TO THE PUBLIC FROM CCF UPON REQUEST.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <Identifier>CHANGES IN NET ASSETS OR FUND BALANCES:</Identifier>
        <ReturnReference>FORM 990, PART XI, LINE 5:</ReturnReference>
        <Explanation>NET UNREALIZED LOSSES ON INVESTMENTS: -1,286,288.</Explanation>
      </GeneralExplanation>
      <GeneralExplanation>
        <ReturnReference>FORM 990, PART XII, LINE 2C</ReturnReference>
        <Explanation>THE PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.</Explanation>
      </GeneralExplanation>
    </IRS990ScheduleO>
    <IRS990ScheduleR documentId="RetDoc1043400001">
      <Form990ScheduleRPartII>
        <NameOfDisregardedEntity>
          <BusinessNameLine1>AMERICAN SOCIETY OF CLINICAL ONCOLOGY INC</BusinessNameLine1>
        </NameOfDisregardedEntity>
        <AddressUS>
          <AddressLine1>2318 MILL ROAD 800</AddressLine1>
          <City>ALEXANDRIA</City>
          <State>VA</State>
          <ZIPCode>22314</ZIPCode>
        </AddressUS>
        <EIN>136180380</EIN>
        <PrimaryActivities>SUPPORTS CANCER RESEARCH, EDUCATION AND QUALITY IMPROVEMENT PROGRAMS</PrimaryActivities>
        <LegalDomicileState>NY</LegalDomicileState>
        <ExemptCodeSection>501(C)(3)</ExemptCodeSection>
        <PublicCharityStatus>LINE 9</PublicCharityStatus>
        <DirectControllingEntityNA>N/A</DirectControllingEntityNA>
        <ControlledOrg>0</ControlledOrg>
      </Form990ScheduleRPartII>
      <ReceiptOfIntAnnRentsRoyalties>0</ReceiptOfIntAnnRentsRoyalties>
      <GiftGrantOrCapContrToOtherOrg>1</GiftGrantOrCapContrToOtherOrg>
      <GiftGrantOrCapContrFrOtherOrg>1</GiftGrantOrCapContrFrOtherOrg>
      <LoansOrGuaranteesToOtherOrg>1</LoansOrGuaranteesToOtherOrg>
      <LoansOrGuaranteesFromOtherOrg>0</LoansOrGuaranteesFromOtherOrg>
      <SaleOfAssetsToOtherOrg>0</SaleOfAssetsToOtherOrg>
      <PurchaseOfAssetsFromOtherOrg>0</PurchaseOfAssetsFromOtherOrg>
      <ExchangeOfAssets>0</ExchangeOfAssets>
      <RentalOfFacilitiesToOtherOrgs>0</RentalOfFacilitiesToOtherOrgs>
      <RentalOfFacilitiesFrOtherOrgs>1</RentalOfFacilitiesFrOtherOrgs>
      <PerformOfServicesForOtherOrgs>1</PerformOfServicesForOtherOrgs>
      <PerformOfServicesByOtherOrgs>0</PerformOfServicesByOtherOrgs>
      <SharingOfFacilities>0</SharingOfFacilities>
      <SharingOfPaidEmployees>1</SharingOfPaidEmployees>
      <ReimbursementPaidToOtherOrg>1</ReimbursementPaidToOtherOrg>
      <ReimbursementPaidByOtherOrg>1</ReimbursementPaidByOtherOrg>
      <OtherTransferToOtherOrg>0</OtherTransferToOtherOrg>
      <OtherTransferFromOtherOrg>0</OtherTransferFromOtherOrg>
      <TransactionsRelatedOrgsTable>
        <NameOfOtherOrganization>
          <BusinessNameLine1>AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO)</BusinessNameLine1>
        </NameOfOtherOrganization>
        <TransactionType>C</TransactionType>
        <AmountInvolved>871450</AmountInvolved>
      </TransactionsRelatedOrgsTable>
      <TransactionsRelatedOrgsTable>
        <NameOfOtherOrganization>
          <BusinessNameLine1>ASCO</BusinessNameLine1>
        </NameOfOtherOrganization>
        <TransactionType>B</TransactionType>
        <AmountInvolved>7731584</AmountInvolved>
      </TransactionsRelatedOrgsTable>
      <TransactionsRelatedOrgsTable>
        <NameOfOtherOrganization>
          <BusinessNameLine1>ASCO</BusinessNameLine1>
        </NameOfOtherOrganization>
        <TransactionType>D</TransactionType>
        <AmountInvolved>64000000</AmountInvolved>
      </TransactionsRelatedOrgsTable>
      <TransactionsRelatedOrgsTable>
        <NameOfOtherOrganization>
          <BusinessNameLine1>ASCO</BusinessNameLine1>
        </NameOfOtherOrganization>
        <TransactionType>K</TransactionType>
        <AmountInvolved>4676846</AmountInvolved>
      </TransactionsRelatedOrgsTable>
      <TransactionsRelatedOrgsTable>
        <NameOfOtherOrganization>
          <BusinessNameLine1>ASCO</BusinessNameLine1>
        </NameOfOtherOrganization>
        <TransactionType>N</TransactionType>
        <AmountInvolved>2560538</AmountInvolved>
      </TransactionsRelatedOrgsTable>
      <TransactionsRelatedOrgsTable>
        <NameOfOtherOrganization>
          <BusinessNameLine1>ASCO</BusinessNameLine1>
        </NameOfOtherOrganization>
        <TransactionType>J</TransactionType>
        <AmountInvolved>231180</AmountInvolved>
      </TransactionsRelatedOrgsTable>
      <TransactionsRelatedOrgsTable>
        <NameOfOtherOrganization>
          <BusinessNameLine1>ASCO</BusinessNameLine1>
        </NameOfOtherOrganization>
        <TransactionType>O</TransactionType>
        <AmountInvolved>5425123</AmountInvolved>
      </TransactionsRelatedOrgsTable>
      <TransactionsRelatedOrgsTable>
        <NameOfOtherOrganization>
          <BusinessNameLine1>ASCO</BusinessNameLine1>
        </NameOfOtherOrganization>
        <TransactionType>P</TransactionType>
        <AmountInvolved>2327368</AmountInvolved>
      </TransactionsRelatedOrgsTable>
    </IRS990ScheduleR>
  </ReturnData>
</Return>